<SEC-DOCUMENT>0001140361-25-007645.txt : 20250307
<SEC-HEADER>0001140361-25-007645.hdr.sgml : 20250307
<ACCEPTANCE-DATETIME>20250307165836
ACCESSION NUMBER:		0001140361-25-007645
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		16
FILED AS OF DATE:		20250307
DATE AS OF CHANGE:		20250307

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TORONTO DOMINION BANK
		CENTRAL INDEX KEY:			0000947263
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		IRS NUMBER:				135640479
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-283969
		FILM NUMBER:		25720944

	BUSINESS ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
		BUSINESS PHONE:		416-944-6367

	MAIL ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>ef20045091_424b2.htm
<DESCRIPTION>PRICING SUPPLEMENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, LLC
         Document created using Broadridge PROfile 25.2.1.5287
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Arial; font-size: 9pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zf02c91115d9c4da8a956e5cc85b5c6c0">

          <tr>
            <td style="width: 50%; vertical-align: top;">
              <div style="font-size: 6pt;">Pricing Supplement dated March 6, 2025 to the</div>
              <div style="font-size: 6pt;">Product Supplement MLN-EI-1 dated February 26, 2025,</div>
              <div style="font-size: 6pt;">Underlier Supplement dated February 26, 2025 and</div>
              <div style="font-size: 6pt;">Prospectus Dated February 26, 2025</div>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="text-align: right; font-size: 6pt;">Filed Pursuant to Rule 424(b)(2)</div>
              <div style="text-align: right; font-size: 6pt;">Registration Statement No. 333-283969</div>
              <div>&#160;</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div><img width="56" height="51" src="image1.jpg"></div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: center; font-size: 7.5pt; font-weight: bold;">The Toronto-Dominion Bank</div>
              <div style="text-align: center; font-size: 7.5pt; font-weight: bold;">$500,000</div>
              <div style="text-align: center; margin-right: 22.5pt; margin-left: 27pt; font-size: 7.5pt; font-weight: bold;"><font style="color: rgb(0, 0, 0);">Autocallable Contingent Interest Barrier Notes Linked to the Least Performing of the Dow Jones
                  Industrial Average</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174; </sup><font style="color: rgb(0, 0, 0);">and the</font>&#160;<font style="color: rgb(0, 0, 0);">Nasdaq-100 Index</font><sup style="color: #000000; vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="color: rgb(0, 0, 0);">&#160;</font>Due March 10, 2027</div>
              <div style="text-align: center; font-size: 7.5pt; font-weight: bold;">Senior Debt Securities, Series H</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 6pt; font-weight: bold;">General</div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 2pt;" class="DSPFListTable" id="z2756f488901444e0837fa5dfecc9fb9d">

          <tr>
            <td style="width: 13.5pt; vertical-align: top; font-size: 6pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 6pt;">The Notes are designed for investors who (i) wish to receive a Contingent Interest Payment (as defined below) if on any Review Date the Closing Level of <font style="font-weight: bold;">each</font> Reference
                Asset (as defined below) is greater than or equal to its Barrier Level (as defined below), (ii) are willing to accept the risk of losing a significant portion or all of their Principal Amount and of not receiving any Contingent Interest
                Payments over the term of the Notes and (iii) are willing to forgo fixed interest and dividend payments. Contingent Interest Payments should not be viewed as periodic interest payments. <font style="font-weight: bold;">Investors will be
                  exposed to the market risk of each Reference Asset and any decline in the level of one Reference Asset may negatively affect their return on the Notes and will not be offset or mitigated by a lesser decline or any potential increase in
                  the level of any other Reference Asset.</font></div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 2pt;" class="DSPFListTable" id="ze032568978a4475a814691c518e90b86">

          <tr>
            <td style="width: 13.3pt; vertical-align: top; font-size: 6pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 6pt;">The Notes will be automatically called prior to the Maturity Date if the Closing Level of <font style="font-weight: bold;">each</font> Reference Asset is greater than or equal to its Initial Level on any Review
                Date other than the Final Review Date. If the Notes are not automatically called and the Closing Level of <font style="font-weight: bold;">any</font> Reference Asset on the Final Review Date (its &#8220;Final Level&#8221;) is less than its Barrier
                Level, investors will suffer a loss on their initial investment that is equal to the percentage decline of the Reference Asset with the lowest percentage change from its Initial Level to its Final Level (the &#8220;Least Performing Reference
                Asset&#8221;) over the term of the Notes. Specifically, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Level of the Least Performing Reference Asset is less than its Initial Level, and may lose the entire
                Principal Amount.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 2pt;" class="DSPFListTable" id="z6547cde91a2e4142b32c16872fd86e65">

          <tr>
            <td style="width: 13.3pt; vertical-align: top; font-size: 6pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 6pt;">Any payments on the Notes, including any repayment of principal, are subject to our credit risk.</div>
            </td>
          </tr>

      </table>
      <div style="margin-top: 4pt; margin-bottom: 2pt; font-size: 6pt; font-weight: bold;">Key Terms</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd45eecef7da54b03ad065e116d4ce053">

          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Issuer:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">The Toronto-Dominion Bank (&#8220;TD&#8221;)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Reference Assets:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">The Dow Jones Industrial Average<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (Bloomberg ticker: &#8220;INDU&#8221; and the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (Bloomberg ticker: &#8220;NDX&#8221;)</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Principal Amount:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">$1,000 per Note, subject to a minimum investment of $10,000 and integral multiples of $1,000 in excess thereof.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Term:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">Approximately 2 years, subject to an automatic call.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Strike Date</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="margin-bottom: 2pt; font-size: 6pt;">March 5, 2025</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Pricing Date:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="margin-bottom: 2pt; font-size: 6pt;">March 6, 2025</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Issue Date:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">March 11, 2025, which is the third DTC settlement day following the Pricing Date. See &#8220;Supplemental Plan of Distribution (Conflicts of Interest)&#8221; herein.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Maturity Date:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">March 10, 2027, subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplement.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Call Feature:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">If the Closing Level of <font style="font-weight: bold;">each</font> Reference Asset on any Review Date other than the Final Review Date is greater than or equal to its
                Initial Level, we will automatically call the Notes and, on the applicable Call Payment Date, we will pay you a cash payment equal to the Principal Amount, plus the Contingent Interest Payment otherwise due. No further amounts will be owed
                to you under the Notes.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Call Payment Date:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">If the Notes are subject to an automatic call, the Call Payment Date will be the Contingent Interest Payment Date immediately following the relevant Review Date.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Review Dates:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">Quarterly, on the 5<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> calendar day of each March, June, September and December, commencing on June 5, 2025 and ending on March 5, 2027 (the &#8220;Final Review Date&#8221;).
                Each Review Date is subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplement.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Contingent Interest</div>
              <div style="font-size: 6pt;">Payment Feature:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">If the Closing Level of <font style="font-weight: bold;">each</font> Reference Asset on any Review Date is greater than or equal to its Barrier Level, a Contingent
                Interest Payment will be paid to you on the corresponding Contingent Interest Payment Date<font style="font-weight: bold;">. Contingent Interest Payments on the Notes are not guaranteed. You will not receive a Contingent Interest Payment on
                  a Contingent Interest Payment Date if the Closing Level of any Reference Asset on any Review Date is less than its Barrier Level. </font>Any Contingent Interest Payment due on a Note will be paid to the registered holder of such Note, as
                determined on the record date, which will be the Business Day preceding the relevant Contingent Interest Payment Date. All amounts used in or resulting from any calculation relating to a Contingent Interest Payment will be rounded upward or
                downward as appropriate, to the nearest tenth of a cent.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Contingent Interest</div>
              <div style="font-size: 6pt;">Payment:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 6pt; margin-bottom: 2pt; font-size: 6pt;">$23.40 per $1,000 Principal Amount of the Notes, if payable.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Contingent Interest</div>
              <div style="font-size: 6pt;">Payment Dates:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">With respect to each Review Date, the third Business Day following the related Review Date, with the exception that the final Contingent Interest Payment Date will be the
                Maturity Date, subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplement.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Payment at Maturity</div>
              <div style="font-size: 6pt;">(if not called):</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="margin-top: 2pt; font-size: 6pt;">If the Notes are not automatically called, on the Maturity Date, in addition to any Contingent Interest Payment otherwise due, we will pay a cash payment, if anything, per Note equal to:</div>
              <div style="text-indent: -9.8pt; margin-left: 12.4pt; margin-top: 2pt;"><font style="font-size: 6pt;">&#8226;&#160;&#160;&#160; If the Final Level of <font style="font-weight: bold;">each</font> Reference Asset is <font style="font-weight: bold;">greater than
                    or equal to </font>its Barrier Level: The Principal Amount of $1,000.</font></div>
              <div style="text-indent: -9.8pt; margin-left: 12.4pt; margin-top: 2pt;"><font style="font-size: 6pt;">&#8226;&#160;&#160;&#160; If <font style="font-weight: bold;">the</font> Final Level of <font style="font-weight: bold;">any </font>Reference Asset is<font style="font-weight: bold;"> less than</font> its Barrier Level: The sum of (1) $1,000 plus (2) the product of (i) $1,000 times (ii) the Least Performing Percentage Change.</font></div>
              <div style="margin-left: 12.4pt; margin-top: 2pt; font-size: 6pt;"><font style="font-weight: bold;">If the Notes are not automatically called and the Final Level of any Reference Asset is less than its Barrier Level, you will suffer a loss on
                  your initial investment that is equal to the percentage change of the Least Performing Reference Asset from its Initial Level to its Final Level (the &#8220;Least Performing Percentage Change&#8221;). Specifically, you will lose 1% of the Principal
                  Amount of the Notes for each 1% that the Final Level of the Least Performing Reference Asset is less than its Initial Level, and may lose your entire Principal Amount. Any payments on the Notes are subject to our credit risk. </font>All
                amounts used in or resulting from any calculation relating to the Payment at Maturity will be rounded upward or downward as appropriate, to the nearest cent.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Percentage Change:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="font-size: 6pt;">For each Reference Asset, the quotient, expressed as a percentage, of the following formula:</div>
              <div style="text-align: center;"><img src="image2.jpg"></div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Least Performing</div>
              <div style="font-size: 6pt;">Reference Asset:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 6pt; margin-bottom: 2pt; font-size: 6pt;">The Reference Asset with the lowest Percentage Change as compared to the Percentage Change of any other Reference Asset.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Least Performing</div>
              <div style="font-size: 6pt;">Percentage Change:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-top: 6pt; margin-bottom: 2pt; font-size: 6pt;">The Percentage Change of the Least Performing Reference Asset.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Initial Level:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">With respect to INDU, 43,006.59</div>
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">With respect to NDX, 20,628.46</div>
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">in each case equal to its Closing Level on the Strike Date, as determined by the Calculation Agent.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Final Level:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">For each Reference Asset, the Closing Level of such Reference Asset on the Final Review Date, as determined by the Calculation Agent.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">Barrier Level:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">With respect to INDU, 30,104.613</div>
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">With respect to NDX, 14,439.922</div>
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">in each case equal to 70.00% of its Initial Level, as determined by the Calculation Agent.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 12%; vertical-align: top;">
              <div style="font-size: 6pt;">CUSIP / ISIN:</div>
            </td>
            <td style="width: 88%; vertical-align: top;">
              <div style="text-align: justify; margin-bottom: 2pt; font-size: 6pt;">89115H3F2 / US89115H3F22</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 2pt; margin-bottom: 2pt; font-size: 6pt;">The estimated value of your Notes on the Pricing Date was $987.90 per Note, as discussed further under &#8220;Additional Risk Factors &#8212; Risks Relating to Estimated Value
        and Liquidity&#8221; beginning on page P-5 and &#8220;Additional Information Regarding the Estimated Value of the Notes&#8221; on page P-20 of this pricing supplement. The estimated value is less than the public offering price of the Notes.</div>
      <div style="text-align: justify; margin-top: 2pt; margin-bottom: 2pt; font-size: 6pt;">The Notes are unsecured and are not savings accounts or insured deposits of a bank. The Notes are not insured or guaranteed by the Canada Deposit Insurance
        Corporation, the U.S. Federal Deposit Insurance Corporation or any other governmental agency or instrumentality.The Notes will not be listed or displayed on any securities exchange or any electronic communications network.</div>
      <div style="text-align: justify; margin-top: 2pt; margin-bottom: 2pt; font-size: 6pt; font-weight: bold;">The Notes have complex features and investing in the Notes involves a number of risks. See &#8220;Additional Risk Factors&#8221; beginning on page P-3 of
        this pricing supplement, &#8220;Additional Risk Factors Specific to the Notes&#8221; beginning on page PS-7 of the product supplement MLN-EI-1 dated February 26, 2025 (the &#8220;product supplement&#8221;) and &#8220;Risk Factors&#8221; on page 1 of the prospectus dated February 26,
        2025 (the &#8220;prospectus&#8221;). Neither the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) nor any state securities commission has approved or disapproved of these Notes or determined that this pricing supplement, the product supplement, the
        underlier supplement or the prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z0f96c807edaa4ef7bec75347b91a3bfd">

          <tr>
            <td style="width: 20.81%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">&#160;</td>
            <td style="width: 25.03%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.5pt; font-size: 6pt; font-weight: bold;">Public Offering Price<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
            </td>
            <td style="width: 25.03%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.5pt; font-size: 6pt; font-weight: bold;">Underwriting Discount<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup></div>
            </td>
            <td style="width: 29.12%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.5pt; font-size: 6pt; font-weight: bold;">Proceeds to TD<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup></div>
            </td>
          </tr>
          <tr>
            <td style="width: 20.81%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.5pt; color: rgb(0, 0, 0); font-size: 6pt;">Per Note</div>
            </td>
            <td style="width: 25.03%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.45pt; color: rgb(0, 0, 0); font-size: 6pt;">$1,000.00</div>
            </td>
            <td style="width: 25.03%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.45pt; font-size: 6pt;"><font style="color: rgb(0, 0, 0);">$</font>7.50</div>
            </td>
            <td style="width: 29.12%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.45pt; font-size: 6pt;"><font style="color: rgb(0, 0, 0);">$</font>992.50</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20.81%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.5pt; color: rgb(0, 0, 0); font-size: 6pt;">Total</div>
            </td>
            <td style="width: 25.03%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.45pt; color: rgb(0, 0, 0); font-size: 6pt;">$500,000.00</div>
            </td>
            <td style="width: 25.03%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.45pt; color: rgb(0, 0, 0); font-size: 6pt;">$3,750.00</div>
            </td>
            <td style="width: 29.12%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
              <div style="text-align: justify; text-indent: 1.45pt; color: rgb(0, 0, 0); font-size: 6pt;">$496,250.00</div>
            </td>
          </tr>

      </table>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%;" id="z1494f5574cea4c65b01179d751cc8fab" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 9pt;">
                <div style="text-align: justify; margin-top: 2pt; font-size: 6pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify; margin-top: 2pt; font-size: 6pt;">The public offering price for investors purchasing the Notes in fiduciary accounts may have been as low as $992.50 (99.25%) per Note.</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%;" id="z886aecbf45e6424da8fbd6642e03cf61" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 9pt;">
                <div style="text-align: justify; margin-top: 2pt; font-size: 6pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify; margin-top: 2pt; font-size: 6pt;">TD Securities (USA) LLC (&#8220;TDS&#8221; or the &#8220;Agent&#8221;) will receive a commission of $7.50 per Note sold in this offering. J.P. Morgan Securities LLC, which we refer to as JPMS LLC,
                  and JPMorgan Chase Bank, N.A. will act as placement agents for the Notes and, from the commission to TDS, will receive a placement fee of $7.50 for each Note they sell in this offering to accounts other than fiduciary accounts. TDS and
                  the placement agents will forgo a commission and placement fee for sales to fiduciary accounts. See &#8220;Supplemental Plan of Distribution (Conflicts of Interest)&#8221; in this pricing supplement for additional information.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; margin-top: 2pt; font-size: 6pt;">The public offering price, underwriting discount and proceeds to TD listed above relate to the Notes we issue initially. We may decide to sell additional Notes after the date of this
        pricing supplement, at public offering prices and with underwriting discounts and proceeds to TD that differ from the amounts set forth above. The return (whether positive or negative) on your investment in the Notes will depend in part on the
        public offering price you pay for such Notes.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">1</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-size: 16pt;">Additional Terms of Your Notes</div>
      <div style="text-align: justify; margin-bottom: 12pt;">You should read this pricing supplement together with the prospectus, as supplemented by the product supplement MLN-EI-1 (the &#8220;product supplement&#8221;) and the underlier supplement (the &#8220;underlier
        supplement&#8221;), relating to our Senior Debt Securities, Series H, of which these Notes are a part. Capitalized terms used but not defined in this pricing supplement will have the meanings given to them in the product supplement. In the event of any
        conflict the following hierarchy will govern: first, this pricing supplement; second, the product supplement; third, the underlier supplement; and last, the prospectus. <font style="font-weight: bold; font-style: italic;">The Notes vary from the
          terms described in the product supplement in several important ways. You should read this pricing supplement carefully.</font></div>
      <div style="text-align: justify; margin-bottom: 12pt;">This pricing supplement, together with the documents listed below, contains the terms of the Notes and supersedes all prior or contemporaneous oral statements as well as any other written
        materials including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, brochures or other educational materials of ours. You should carefully consider, among other things, the
        matters set forth under &#8220;Additional Risk Factors&#8221; in this pricing supplement, &#8220;Additional Risk Factors Specific to the Notes&#8221; in the product supplement and &#8220;Risk Factors&#8221; in the prospectus, as the Notes involve risks not associated with
        conventional debt securities. We urge you to consult your investment, legal, tax, accounting and other advisors concerning an investment in the Notes. You may access these documents on the SEC website at www.sec.gov as follows (or if that address
        has changed, by reviewing our filings for the relevant date on the SEC website):</div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%;" id="z75e7d80b48f1489a89e52b11d57f6a86" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="width: 18pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="text-align: justify; font-size: 7pt;">&#9632;</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify;">Prospectus dated February 26, 2025:</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; margin-bottom: 10pt; margin-left: 36pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm">http://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm</a></div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%;" id="z633821eadc54475bb702c2759dabdc93" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="width: 18pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="text-align: justify; font-size: 7pt;">&#9632;</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify;">Underlier Supplement dated February 26, 2025:</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; margin-left: 36pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006121/ef20044458_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006121/ef20044458_424b3.htm</a></div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%;" id="zb8af6bd160de4114942edc9aceaff369" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="width: 18pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 18pt;">
                <div style="text-align: justify; font-size: 7pt;">&#9632;</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify;">Product Supplement MLN-EI-1 dated February 26, 2025:</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; margin-left: 36pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006123/ef20044459_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006123/ef20044459_424b3.htm</a></div>
      <div style="text-align: justify; margin-bottom: 12pt;">Our Central Index Key, or CIK, on the SEC website is 0000947263. As used in this pricing supplement, the &#8220;Bank,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221; refers to The Toronto-Dominion Bank and its subsidiaries.</div>
      <div style="text-align: justify;">We reserve the right to change the terms of, or reject any offer to purchase, the Notes prior to their issuance. In the event of any changes to the terms of the Notes, we will notify you and you will be asked to
        accept such changes in connection with your purchase. You may also choose to reject such changes, in which case we may reject your offer to purchase.</div>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">2</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; color: rgb(0, 176, 80); font-size: 16pt;">Selected Purchase Considerations</div>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;" class="DSPFListTable" id="z9fc3a89a75d14a2ba965675202dc82eb">

          <tr>
            <td style="width: 13.5pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">Limited Return Potential &#8212; </font>The return potential of the Notes is limited to any Contingent Interest Payments you may receive over the term of the Notes and you will not participate in any increase
                in the level of any Reference Asset. If you don&#8217;t receive any Contingent Interest Payments over the term of the Notes, you will not have a positive return on your investment.</div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;" class="DSPFListTable" id="z4591f1022cc74912a78043b3af33147f">

          <tr>
            <td style="width: 13.5pt; vertical-align: top; font-size: 10pt;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-size: 10pt;"><font style="font-size: 9pt; font-weight: bold;">Potential For Automatic Call &#8212; </font><font style="font-size: 9pt;">The Notes will be automatically called if the Closing Level of </font><font style="font-size: 9pt; font-weight: bold;">each</font><font style="font-size: 9pt;"> Reference Asset is greater than or equal to its Initial Level on any Review Date other than the Final Review Date and are, therefore, subject to reinvestment risk. If the
                  Notes are automatically called, on the Call Payment Date, you will receive a cash payment per Note equal to the Principal Amount, plus the Contingent Interest Payment otherwise due.</font></div>
            </td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000; margin-bottom: 6pt;" class="DSPFListTable" id="z1a9871de1cd04beab1843cb4e6b28c3b">

          <tr>
            <td style="width: 13.5pt; vertical-align: top;">&#8226;</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div><font style="font-weight: bold;">Contingent Repayment of Principal, with Potential for Full Downside Exposure &#8212; </font>If the Notes are not automatically called and the Final Level of <font style="font-weight: bold;">each </font>Reference


                Asset is greater than or equal to its Barrier Level, you will receive a cash payment per Note equal to the Principal Amount. If, however, the Notes are not automatically called and the Final Level of <font style="font-weight: bold;">any </font>Reference


                Asset is less than its Barrier Level, you will lose 1% of the Principal Amount of the Notes for each 1% that the Final Level of the Least Performing Reference Asset is less than its Initial Level, and may lose your entire investment in the
                Notes. <font style="font-weight: bold;">You will be exposed to the market risk of each Reference Asset and any decline in the level of one Reference Asset may negatively affect your return on the Notes and will not be offset or mitigated
                  by a lesser decline or any potential increase in the level of any other Reference Asset. Any payments on the Notes, including any repayment of principal, are subject to our credit risk.</font></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 12pt; color: rgb(0, 176, 80); font-size: 16pt;">Additional Risk Factors</div>
      <div style="text-align: justify; margin-top: 6pt;">The Notes involve risks not associated with an investment in conventional debt securities. This section describes the most significant risks relating to the terms of the Notes. For additional
        information as to these risks, please see &#8220;Additional Risk Factors Specific to the Notes&#8221; in the product supplement and &#8220;Risk Factors&#8221; in the prospectus.</div>
      <div style="text-align: justify; margin-top: 6pt;">Investors should consult their investment, legal, tax, accounting and other advisors as to the risks entailed by an investment in the Notes and the suitability of the Notes in light of their
        particular circumstances.</div>
      <div style="text-align: center; margin-top: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Return Characteristics</div>
      <div style="margin-top: 6pt; font-weight: bold;">Your Investment in the Notes May Result in a Loss.</div>
      <div style="text-align: justify; margin-top: 6pt;">The Notes do not guarantee the return of the Principal Amount and investors may lose up to their entire investment in the Notes. Specifically, if the Notes are not automatically called and the Final
        Level of any Reference Asset is less than its Barrier Level, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Level of the Least Performing Reference Asset is less than its Initial Level, and may lose the
        entire Principal Amount.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">You Will Not Receive the Contingent Interest Payment With Respect to a Review Date If the Closing Level of any Reference Asset on such Review Date Is Less Than its Barrier Level.</div>
      <div style="text-align: justify; margin-top: 6pt;">You will not necessarily receive Contingent Interest Payments on the Notes, and thus Contingent Interest Payments should not be viewed as periodic interest payments. You will not receive the
        Contingent Interest Payment with respect to a Review Date if the Closing Level of any Reference Asset on such Review Date is less than its Barrier Level.</div>
      <div style="text-align: justify; margin-top: 6pt;">If the Closing Level of a Reference Asset is less than its Barrier Level on each Review Date over the term of the Notes, you will not receive any Contingent Interest Payments, and you will not
        receive a positive return on, your Notes. Generally, this non-payment of any Contingent Interest Payment will coincide with a greater risk of principal loss on your Notes. Accordingly, if we do not pay any Contingent Interest Payment on the
        Maturity Date, you will incur a loss of principal because the Final Level of the Least Performing Reference Asset will be less than its Barrier Level, and you may lose your entire Principal Amount.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Potential Positive Return on the Notes Is Limited to the Contingent Interest Payments Paid on the Notes, If Any, Regardless of Any Increase in the Level of Any Reference Asset.</div>
      <div style="text-align: justify; margin-top: 6pt;">The potential positive return on the Notes is limited to any Contingent Interest Payments paid, meaning any positive return on the Notes will be composed solely of the sum of any Contingent Interest
        Payments paid over the term of the Notes. Therefore, if the increase of any Reference Asset exceeds the sum of any Contingent Interest Payments actually paid on the Notes, the return on the Notes will be less than the return on a hypothetical
        direct investment in such Reference Asset or the stocks comprising the Reference Assets (the &#8220;Reference Asset Constituents&#8221;) or in a security directly linked to the positive performance of such Reference Asset or the Reference Asset Constituents.</div>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">3</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="color: #000000; font-weight: bold; text-align: justify;">The Contingent Interest Payment Will Reflect, In Part, the Volatility of each Reference Asset and May Not Be Sufficient to Compensate You for the Risk of Loss at Maturity.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="color: rgb(0, 0, 0);">Generally, the higher the Reference Assets&#8217; volatility, the more likely it is that the Closing Level or Final Level, as applicable, of each Reference Asset could be
          less than its Initial Level or its Barrier Level on a Review Date or the Final Review Date, as applicable. Volatility means the magnitude and frequency of changes in the levels of the Reference Assets. This greater risk will generally be
          reflected in a higher Contingent Interest Payment for the Notes than the amount payable on our conventional debt securities of a comparable term. However, while the Contingent Interest Payment is set on the Strike Date, the Reference Assets&#8217;
          volatility can change significantly over the term of the Notes, and may increase. The Closing Level or Final Level, as applicable, of any Reference Asset could fall sharply on the Review Dates, including the Final Review Date, resulting in few or
          no Contingent Interest Payments and in a significant or entire loss </font>of principal<font style="color: rgb(0, 0, 0);">.</font></div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Your Return May Be Less than the Return on a Conventional Debt Security of Comparable Maturity.</div>
      <div style="text-align: justify; margin-top: 6pt; color: rgb(0, 0, 0);">The return that you will receive on your Notes, which could be negative, may be less than the return you could earn on other investments. The Notes do not provide for fixed
        interest payments and you may not receive any Contingent Interest Payments over the term of the Notes. Even if you do receive one or more Contingent Interest Payments and your return on the Notes is positive, your return may be less than the return
        you would earn if you bought a conventional, interest -bearing senior debt security of TD of comparable maturity. Your investment may not reflect the full opportunity cost to you when you take into account factors that affect the time value of
        money.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-weight: bold;">The Notes May Be Automatically Called</font>&#160;<font style="font-weight: bold;">Prior to the Maturity Date</font>&#160;<font style="font-weight: bold;">And Are Subject to
          Reinvestment Risk.</font></div>
      <div style="text-align: justify; margin-top: 6pt;">If your Notes are automatically called, no further payments will be owed to you under the Notes after the applicable Call Payment Date. Therefore, because the Notes could be called as early as the
        first potential Call Payment Date, the holding period could be limited. There is no guarantee that you would be able to reinvest the proceeds from an investment in the Notes at a comparable return for a similar level of risk in the event the Notes
        are automatically called prior to the Maturity Date. Furthermore, to the extent you are able to reinvest such proceeds in an investment with a comparable return for a similar level of risk, you may incur transaction costs such as dealer discounts
        and hedging costs built into the price of the new notes.</div>
      <div style="text-align: justify; margin-top: 6pt;">The Amounts Payable on the Notes, Including the Payment at Maturity, Are Not Linked to the Level of the Least Performing Reference Asset at Any Time Other Than on the Applicable Review Dates,
        including the Final Review Date.</div>
      <div style="text-align: justify; margin-top: 6pt;">Any payments on the Notes, including the Payment at Maturity, will be based on the Closing Level of the Least Performing Reference Asset only on the Review Dates (including the Final Review Date).
        Even if the level of the Least Performing Reference Asset increases at any other time but then drops on that day to a Closing Level that is less than its Barrier Level Date, you will not receive any Contingent Interest Payment with respect to such
        Review Date.</div>
      <div style="text-align: justify; margin-top: 6pt;">In addition, any Payment at Maturity will be calculated by reference to the Final Level of the Least Performing Reference Asset, which will be equal to the Closing Level of such Reference Asset on
        the Final Review Date. In calculating the Final Level of the Least Performing Reference Asset, positive performance of such Reference Asset before or after the Final Review Date that would lead to a positive return on the Notes will not be taken
        into account. Therefore, if the Closing Level of the Least Performing Reference Asset is less than its Barrier Level on the Final Review Date, the return on the Notes will be negative, regardless of its Closing Level on any other day.</div>
      <div style="text-align: center; margin-top: 6pt; color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">Risks Relating to Characteristics of the Reference Asset</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Because the Notes are Linked to the Least Performing Reference Asset, You Are Exposed to a Greater Risk of Not Receiving Any Contingent Interest Payments and Losing a Significant
        Portion or All of Your Initial Investment at Maturity than if the Notes Were Linked to a Single Reference Asset.</div>
      <div style="text-align: justify; margin-top: 6pt;">The risk that you will not receive any Contingent Interest Payments and lose a significant portion or all of your initial investment in the Notes is greater if you invest in the Notes than the risk
        of investing in substantially similar securities that are linked to the performance of only one Reference Asset. With more Reference Assets, it is more likely that the Closing Level of any Reference Asset will be less than its Barrier Level on any
        Review Date and that the Final Level of any Reference Asset will be less than its Barrier Level than if the Notes were linked to a single Reference Asset.</div>
      <div style="text-align: justify; margin-top: 6pt;">In addition, the lower the correlation is between the performance of a pair of Reference Assets, the more likely it is that one of the Reference Assets will decline in level to a Closing Level that
        is less than its Barrier Level on any Review Date and a Final Level that is less than its Barrier Level as of the Final Review Date. Although the correlation of the Reference Assets&#8217; performance may change over the term of the Notes, the economic
        terms of the Notes, including the Contingent Interest Payment and Barrier Levels, are determined, in part, based on the correlation of the Reference Assets&#8217; performance calculated using our internal models at the time when the terms of the Notes
        are finalized. All things being equal, a higher Contingent Interest Payment and lower Barrier Levels are generally associated with lower correlation of the Reference Assets. Therefore, if the performance of a pair of Reference Assets is not
        correlated to each other or is negatively correlated, the risk that you will not receive any Contingent Interest Payments and that the Final Level of any Reference Asset will be less than its Barrier Level is even greater despite lower Barrier
        Levels. Therefore, it is more likely that you will not receive any Contingent Interest Payments and that you will lose a significant portion or all of your initial investment at maturity.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Investors Are Exposed to the Market Risk of Each Reference Asset on Each Review Date (Including the Final Review Date).</div>
      <div style="text-align: justify; margin-top: 6pt;">Your return on the Notes is not linked to a basket consisting of the Reference Assets. Rather, it will be contingent upon the performance of each Reference Asset. Unlike an instrument with a return
        linked to a basket of indices, common stocks or other underlying securities, in which risk is mitigated and diversified among all of the components of the basket, you will be exposed equally to the risks related to each Reference Asset on each
        Review Date (including the Final Review Date). Poor performance by any Reference Asset over the term</div>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">4</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;">of the Notes will negatively affect your return and will not be offset or mitigated by a more favorable performance by any other Reference Asset. For instance, you will receive a negative return equal to the Least
        Performing Percentage Change if the Final Level of any Reference Asset is less than its Barrier Level on its Final Review Date, even if the Percentage Change of another Reference Asset is positive or has not declined as much. Accordingly, your
        investment is subject to the market risk of each Reference Asset.</div>
      <div style="text-align: justify; margin-top: 6pt; color: rgb(0, 0, 0); font-weight: bold;">There Are Market Risks Associated with each Reference Asset.</div>
      <div style="text-align: justify; margin-top: 6pt; color: rgb(0, 0, 0);">The level of each Reference Asset can rise or fall sharply due to factors specific to such Reference Asset, the Reference Asset Constituents and their issuers (the &#8220;Reference
        Asset Constituent Issuers&#8221;), such as stock price volatility, earnings, financial conditions, corporate, industry and regulatory developments, management changes and decisions and other events, as well as general market factors, such as general
        stock market volatility and levels, interest rates and economic and political conditions. You, as an investor in the Notes, should make your own investigation into the Reference Assets. For additional information, see &#8220;Information Regarding the
        Reference Assets&#8221; in this pricing supplement.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">We Have No Affiliation with Any Index Sponsor and Will Not Be Responsible for Any Actions Taken by any Index Sponsor.</div>
      <div style="text-align: justify; margin-top: 6pt;">No Index Sponsor is an affiliate of ours and no such entity will be involved in the offering of the Notes in any way. Consequently, we have no control over the actions of any Index Sponsor, including
        any actions of the type that would require the Calculation Agent to adjust any amounts payable on the Notes. No Index Sponsor has any obligation of any sort with respect to the Notes. Thus, no Index Sponsor has any obligation to take your interests
        into consideration for any reason, including in taking any actions that might affect the level of the applicable Reference Asset and, therefore, the market value of, and any amounts payable on, the Notes. Except pursuant to any license agreement
        with an Index Sponsor and specified in &#8220;Information Regarding the Reference Assets&#8221; below, none of the proceeds from the issuance of the Notes will be delivered to any Index Sponsor.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Changes that Affect the Reference Asset May Adversely Affect the Market Value of, and Return on, the Notes.</div>
      <div style="text-align: justify; margin-top: 6pt;">The policies of the Index Sponsor concerning the calculation of the Reference Asset, additions, deletions or substitutions of the Reference Asset Constituents and the manner in which changes
        affecting those Reference Asset Constituents, such as stock dividends, reorganizations or mergers, may be reflected in the Reference Asset and could adversely affect the market value of, and return on, the Notes. The market value of, and return on,
        the Notes could also be affected if the Index Sponsor changes these policies, for example, by changing the manner in which it calculates the Reference Asset, or if the Index Sponsor discontinues or suspends calculation or publication of the
        Reference Asset. If events such as these occur, the Calculation Agent may select a successor index or take other actions as discussed in the product supplement and, notwithstanding these adjustments, the market value of, and return on, the Notes
        may be adversely affected.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Dow Jones Industrial Average<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> and Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Reflect Price Return, not Total Return.</div>
      <div style="text-align: justify; margin-top: 6pt;">The return on your Notes is based on the performance of the Dow Jones Industrial Average<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> and the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, which reflect the changes in the market prices of their
        respective Reference Asset Constituents. The Dow Jones Industrial Average<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> and the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> is not a &#8220;total return&#8221; index or strategy, which, in addition to reflecting those price returns, would also reflect dividends
        paid on its Reference Asset Constituents. The return on the Notes will not include such a total return feature or dividend component.</div>
      <div style="text-align: center; margin-top: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Estimated Value and Liquidity</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Estimated Value of Your Notes Is Less Than the Public Offering Price of Your Notes.</div>
      <div style="text-align: justify; margin-top: 6pt;">The estimated value of your Notes is less than the public offering price of your Notes. The difference between the public offering price of your Notes and the estimated value of the Notes reflects
        costs and expected profits associated with selling and structuring the Notes, as well as hedging our obligations under the Notes. Because hedging our obligations entails risks and may be influenced by market forces beyond our control, this hedging
        may result in a profit that is more or less than expected, or a loss.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Estimated Value of Your Notes Is Based on Our Internal Funding Rate.</div>
      <div style="text-align: justify; margin-top: 6pt;">The estimated value of your Notes is determined by reference to our internal funding rate. The internal funding rate used in the determination of the estimated value of the Notes generally represents
        a discount from the credit spreads for our conventional, fixed-rate debt securities and the borrowing rate we would pay for our conventional, fixed-rate debt securities. This discount is based on, among other things, our view of the funding value
        of the Notes as well as the higher issuance, operational and ongoing liability management costs of the Notes in comparison to those costs for our conventional, fixed-rate debt, as well as estimated financing costs of any hedge positions, taking
        into account regulatory and internal requirements. If the interest rate implied by the credit spreads for our conventional, fixed-rate debt securities, or the borrowing rate we would pay for our conventional, fixed-rate debt securities were to be
        used, we would expect the economic terms of the Notes to be more favorable to you. Additionally, assuming all other economic terms are held constant, the use of an internal funding rate for the Notes is expected to increase the estimated value of
        the Notes at any time.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Estimated Value of the Notes Is Based on Our Internal Pricing Models, Which May Prove to Be Inaccurate and May Be Different from the Pricing Models of Other Financial
        Institutions.</div>
      <div style="text-align: justify; margin-top: 6pt;">The estimated value of your Notes is based on our internal pricing models, which take into account a number of variables, such as our internal funding rate on the Pricing Date, and are based on a
        number of subjective assumptions, which are not evaluated or verified on an independent basis and may or may not materialize. Further, our pricing models may be different from other financial institutions&#8217; pricing models and the methodologies used
        by us to estimate the value of the Notes may not be consistent with those of other financial institutions that may be purchasers or sellers of Notes in the secondary market. As a result, the secondary market price of your Notes may be</div>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">5</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;">materially less than the estimated value of the Notes determined by reference to our internal pricing models. In addition, market conditions and other relevant factors in the future may change, and any assumptions
        may prove to be incorrect.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Estimated Value of Your Notes Is Not a Prediction of the Prices at Which You May Sell Your Notes in the Secondary Market, If Any, and Such Secondary Market Prices, If Any, Will
        Likely be Less Than the Public Offering Price of Your Notes and May Be Less Than the Estimated Value of Your Notes.</div>
      <div style="text-align: justify; margin-top: 6pt;">The estimated value of the Notes is not a prediction of the prices at which the Agent, other affiliates of ours or third parties may be willing to purchase the Notes from you in secondary market
        transactions (if they are willing to purchase, which they are not obligated to do). The price at which you may be able to sell your Notes in the secondary market at any time, if any, will be influenced by many factors that cannot be predicted, such
        as market conditions, and any bid and ask spread for similar sized trades, and may be substantially less than the estimated value of the Notes. Further, as secondary market prices of your Notes take into account the levels at which our debt
        securities trade in the secondary market, and do not take into account our various costs and expected profits associated with selling and structuring the Notes, as well as hedging our obligations under the Notes, secondary market prices of your
        Notes will likely be less than the public offering price of your Notes. As a result, the price at which the Agent, other affiliates of ours or third parties may be willing to purchase the Notes from you in secondary market transactions, if any,
        will likely be less than the price you paid for your Notes, and any sale prior to the Maturity Date could result in a substantial loss to you.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;"><font style="color: rgb(0, 0, 0);">If the Level of any Reference </font>Asset<font style="color: rgb(0, 0, 0);"> Changes, the Market Value of Your Notes May Not Change in the Same
          Manner.</font></div>
      <div style="text-align: justify; margin-top: 6pt;">Your Notes may trade quite differently from the performance of any of the Reference Assets. Changes in the level of any Reference <font style="color: rgb(0, 0, 0);">Asset may not result in a
          comparable change in </font>the<font style="color: rgb(0, 0, 0);"> market value of your Notes. Even if the Closing Level of each Reference Asset remains greater than or equal to its Barrier </font>Level<font style="color: rgb(0, 0, 0);"> or
          increases to greater than its Initial Level during the term of the Notes, the market value of your Notes may not increase by the same amount and could decline.</font></div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Temporary Price at Which the Agent May Initially Buy the Notes in the Secondary Market May Not Be Indicative of Future Prices of Your Notes.</div>
      <div style="text-align: justify; margin-top: 6pt;">Assuming that all relevant factors remain constant after the Pricing Date, the price at which the Agent may initially buy or sell the Notes in the secondary market (if the Agent makes a market in the
        Notes, which it is not obligated to do) may exceed the estimated value of the Notes on the Pricing Date, as well as the secondary market value of the Notes, for a temporary period after the Issue Date of the Notes, as discussed further under
        &#8220;Additional Information Regarding the Estimated Value of the Notes.&#8221; The price at which the Agent may initially buy or sell the Notes in the secondary market may not be indicative of future prices of your Notes.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Underwriting Discount, Offering Expenses and Certain Hedging Costs Are Likely to Adversely Affect Secondary Market Prices.</div>
      <div style="text-align: justify; margin-top: 6pt;">Assuming no changes in market conditions or any other relevant factors, the price, if any, at which you may be able to sell the Notes will likely be less than the public offering price. The public
        offering price includes, and any price quoted to you is likely to exclude, the underwriting discount paid in connection with the initial distribution, offering expenses as well as the cost of hedging our obligations under the Notes. In addition,
        any such price is also likely to reflect dealer discounts, mark-ups and other transaction costs, such as a discount to account for costs associated with establishing or unwinding any related hedge transaction.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">There May Not Be an Active Trading Market for the Notes &#8212; Sales in the Secondary Market May Result in Significant Losses.</div>
      <div style="text-align: justify; margin-top: 6pt;">There may be little or no secondary market for the Notes. The Notes will not be listed or displayed on any securities exchange or any electronic communications network. The Agent or another of our
        affiliates may make a market for the Notes; however, they are not required to do so and may stop any market-making activities at any time. Even if a secondary market for the Notes develops, it may not provide significant liquidity or trade at
        prices advantageous to you. We expect that transaction costs in any secondary market would be high. As a result, the difference between bid and ask prices for your Notes in any secondary market could be substantial.</div>
      <div style="text-align: justify; margin-top: 6pt;">If you sell your Notes before an automatic call or the Maturity Date, you may have to do so at a substantial discount from the public offering price irrespective of the level of the then-current
        Least Performing Reference Asset at such time, and as a result, you may suffer substantial losses.</div>
      <div style="text-align: center; margin-top: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Hedging Activities and Conflicts of Interest</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">There Are Potential Conflicts of Interest Between You and the Calculation Agent.</div>
      <div style="text-align: justify; margin-top: 6pt;">The Calculation Agent will, among other things, determine the amounts payable on the Notes. We will serve as the Calculation Agent and may appoint a different Calculation Agent after the Issue Date
        without notice to you. The Calculation Agent will exercise its judgment when performing its functions. For example, the Calculation Agent may have to determine whether a Market Disruption Event affecting a Reference Asset has occurred, and make
        certain adjustments if certain events occur, which may, in turn, depend on the Calculation Agent&#8217;s judgment as to whether the event has materially interfered with our ability or the ability of one of our affiliates to unwind our hedge positions.
        Because this determination by the Calculation Agent may affect the amounts payable on the Notes, the Calculation Agent may have a conflict of interest if it needs to make a determination of this kind. For additional information on the Calculation
        Agent&#8217;s role, see &#8220;General Terms of the Notes &#8212; Role of Calculation Agent&#8221; in the product supplement.</div>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">6</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="font-weight: bold; text-align: justify;">Any Review Date (including the Final Review Date) and the Related Payment Dates are Subject to Market Disruption Events and Postponement.</div>
      <div style="text-align: justify; margin-top: 6pt;">Each Review Date (including the Final Review Date) and the related payment dates (including the Maturity Date) are subject to postponement as described herein and in the product supplement due to the
        occurrence of one of more market disruption events. For a description of what constitutes a Market Disruption Event as well as the consequences of that Market Disruption Event, see &#8220;Additional Terms&#8212;Market Disruption Events&#8221; herein and &#8220;General
        Terms of the Notes&#8212;Market Disruption Events&#8221; in the product supplement. A market disruption event for a particular Reference Asset will not constitute a market disruption event for any other Reference Asset.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Trading and Business Activities by TD or its Affiliates May Adversely Affect the Market Value of, and Any Amounts Payable on, the Notes.</div>
      <div style="text-align: justify; margin-top: 6pt;">We, the Agent and/or one or more of our other affiliates may hedge our obligations under the Notes by purchasing securities, futures, options or other derivative instruments with returns linked or
        related to changes in the levels of one or more Reference Assets or one or more Reference Asset Constituents, and we may adjust these hedges by, among other things, purchasing or selling at any time any of the foregoing assets. It is possible that
        we and/or one or more of our affiliates could receive substantial returns from these hedging activities while the market value of, and any amounts payable on, the Notes declines. We and/or one or more of our affiliates may also issue or underwrite
        other securities or financial or derivative instruments with returns linked or related to changes in the performance of a Reference Asset or one or more Reference Asset Constituents.</div>
      <div style="text-align: justify; margin-top: 6pt;">These trading activities may present a conflict between the holders&#8217; interest in the Notes and the interests we and/or our affiliates will have in our or their proprietary accounts, in facilitating
        transactions, including options and other derivatives transactions, for our and/or their customers&#8217; accounts and in accounts under our and/or their management. These trading activities could be adverse to the interests of the holders of the Notes.</div>
      <div style="text-align: justify; margin-top: 6pt;">We, the Agent and/or another of our affiliates may, at present or in the future, engage in business with one or more Reference Asset Constituent Issuers, such as making loans or providing investment
        banking and merger and acquisition advisory services. These business activities may present a conflict between our and/or one or more of our affiliates&#8217; (including the Agent&#8217;s) obligations and your interests as a holder of the Notes. Moreover, we,
        the Agent and/or another of our affiliates may have published, and in the future expect to publish, research reports with respect to one or more Reference Assets or one or more Reference Asset Constituent Issuers. This research is modified from
        time to time without notice and may express opinions or provide recommendations that are inconsistent with purchasing or holding the Notes. Any of these activities by us, the Agent and/or another of our affiliates may affect the levels of such
        Reference Assets and, therefore, the market value of, and any payments on, the Notes.</div>
      <div style="text-align: center; margin-top: 6pt; font-style: italic; font-weight: bold;">Risks Relating to General Credit Characteristics</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Investors Are Subject to TD&#8217;s Credit Risk, and TD&#8217;s Credit Ratings and Credit Spreads May Adversely Affect the Market Value of the Notes.</div>
      <div style="text-align: justify; margin-top: 6pt;">Although the return on the Notes will be based on the performance of the Least Performing Reference Asset, the payment of any amount due on the Notes is subject to TD&#8217;s credit risk. The Notes are
        TD&#8217;s senior unsecured debt obligations. Investors are dependent on TD&#8217;s ability to pay all amounts due on the Notes and, therefore, investors are subject to the credit risk of TD and to changes in the market&#8217;s view of TD&#8217;s creditworthiness. Any
        decrease in TD&#8217;s credit ratings or increase in the credit spreads charged by the market for taking TD&#8217;s credit risk is likely to adversely affect the market value of the Notes. If TD becomes unable to meet its financial obligations as they become
        due, investors may not receive any amounts due under the terms of the Notes.</div>
      <div style="text-align: center; margin-top: 6pt; font-style: italic; font-weight: bold;">Risks Relating to Canadian and U.S. Federal Income Taxation</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Significant Aspects of the Tax Treatment of the Notes Are Uncertain.</div>
      <div style="text-align: justify; margin-top: 6pt;">Significant aspects of the U.S. tax treatment of the Notes are uncertain. You should consult your tax advisor about your tax situation and should read carefully the sections entitled &#8220;Material U.S.
        Federal Income Tax Consequences&#8221; herein and in the product supplement. You should consult your tax advisor as to the tax consequences of your investment in the Notes.</div>
      <div style="text-align: justify; margin-top: 6pt;">The U.S. federal income tax treatment of the Contingent Interest Payments is unclear with respect to non-U.S. holders. <font style="font-weight: bold;">Accordingly, we will treat any Contingent
          Interest Payments on the Notes as subject to a 30% U.S. withholding tax. To the extent we have withholding responsibilities with respect to a Note, we intend to withhold such tax on any Contingent Interest Payment and we anticipate that other
          withholding agents would do the same. You are urged to consult your tax advisors regarding the application of the withholding tax to your Notes and the availability of any reduction in tax pursuant to an income tax treaty. No assurance can be
          given that you will be able to successfully claim a reduction in tax pursuant to an applicable income tax treaty. We will not pay any additional amounts in respect of any such withholding.</font></div>
      <div style="text-align: justify; margin-top: 6pt;">For a discussion of the Canadian federal income tax consequences of investing in the Notes, please see the discussion in the prospectus under &#8220;Tax Consequences &#8212; Canadian Taxation&#8221; and in the product
        supplement under &#8220;Supplemental Discussion of Canadian Tax Consequences&#8221; and the further discussion herein under &#8220;Additional Terms&#8221;. If you are not a Non-resident Holder (as that term is defined in the prospectus) for Canadian federal income tax
        purposes or if you acquire the Notes in the secondary market, you should consult your tax advisors as to the consequences of acquiring, holding and disposing of the Notes and receiving the payments that might be due under the Notes.</div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">7</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z04136a3899924670aa03c1fb2382ec37">

          <tr>
            <td style="width: 100%; vertical-align: middle;">
              <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt; font-weight: bold;">Autocallable Contingent Interest Barrier Notes</div>
              <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt; font-weight: bold;">Linked to the Least Performing of the Dow Jones Industrial Average<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> and the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
              <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt; font-weight: bold;">Due March 10, 2027</div>
            </td>
          </tr>
          <tr>
            <td style="width: 100%; vertical-align: middle;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="4" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="za6b8103ec74e41d38ab43767321faaec">

          <tr>
            <td style="width: 100%; vertical-align: top; background-color: #000000;">&#160;</td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 12pt; margin-bottom: 6pt; color: rgb(0, 176, 80); font-size: 16pt;">Additional Terms</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The information in this &#8220;Additional Terms&#8221; section supplements, and to the extent inconsistent supersedes, the information set forth in the product supplement, the underlier supplement and the
        prospectus.</div>
      <table cellspacing="0" cellpadding="4" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1e8388eba7d44659a2f521eeee8bdffa">

          <tr>
            <td style="width: 23%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Issue:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Senior Debt Securities, Series H</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Type of Note:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Autocallable Contingent Interest Barrier Notes</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Agent:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">TDS</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Currency:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">U.S. Dollars</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Monitoring Period:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">With respect to each Reference Asset, for purposes of the determination of the Final Level, the Calculation Agent will observe the Closing Level of such Reference Asset on the Final Review
                Date.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Change in Law Event:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Not applicable, notwithstanding anything to the contrary in the product supplement.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Canadian Tax Treatment:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Please see the discussion in the prospectus under &#8220;Tax Consequences &#8212; Canadian Taxation&#8221; and in the product supplement under &#8220;Supplemental Discussion of Canadian Tax Consequences&#8221;, which
                applies to the Notes. We will not pay any additional amounts as a result of any withholding required by reason of the rules governing hybrid mismatch arrangements contained in section 18.4 of the Canadian Tax Act (as defined in the
                prospectus).</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Business Day:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">Any day that is a Monday, Tuesday, Wednesday, Thursday or Friday that is neither a legal holiday nor a day on which banking institutions are authorized or required by law to close in New
                York City.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Calculation Agent:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">TD</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Listing:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify; margin-bottom: 3pt;">The Notes will not be listed or displayed on any securities exchange or electronic communications network.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 23%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="font-weight: bold; text-align: justify;">Canadian Bail-in:</div>
            </td>
            <td style="width: 77%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
              <div style="text-align: justify;">The Notes are not bail-inable debt securities (as described in the prospectus) under the Canada Deposit Insurance Corporation Act.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">8</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 6pt; color: rgb(0, 176, 80); font-size: 16pt;">Hypothetical Returns</div>
      <div style="text-align: justify; margin-top: 6pt;">The examples set out below are included for illustration purposes only and are hypothetical examples only; amounts below may have been rounded for ease of analysis. The hypothetical Initial Level,
        Closing Levels, Final Level and<font style="font-weight: bold;">&#160;</font>Percentage Changes of the Reference Assets used to illustrate the calculation of whether a Contingent Interest Payment is payable on a Contingent Interest Payment Date and the
        Payment at Maturity are not estimates or forecasts of the actual Initial Level, the Closing Level, the Final Level or the level of any Reference Asset on any Trading Day prior to the Maturity Date. All examples assume, for each Reference Asset, an
        Initial Level of 100.00, a Barrier Level of 70.00 (70.00% of the applicable Initial Level), a Contingent Interest Payment of $23.40 per Note, that the Notes may be subject to an automatic call on any Review Date other than the Final Review Date,
        that a holder purchased Notes with a Principal Amount of $1,000 and that no Market Disruption Event occurs on any Review Date, including the Final Review Date. The actual terms of the Notes are indicated on the cover page hereof.</div>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td nowrap="nowrap" style="width: 10%; vertical-align: bottom; font-weight: bold;" rowspan="1">Example 1 &#8212;</td>
            <td nowrap="nowrap" style="width: 90%; vertical-align: bottom; font-weight: bold;" rowspan="1">The Notes Are Automatically Called on the First Call Payment Date.</td>
          </tr>

      </table>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td nowrap="nowrap" style="width: 14%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Review Date</div>
            </td>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Closing Levels</div>
            </td>
            <td style="width: 2.05%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" style="width: 34%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Payment (per Note)</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 14%; vertical-align: top;">
              <div style="margin-top: 3pt; color: rgb(0, 0, 0);">First</div>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="margin-top: 3pt;"><font style="color: rgb(0, 0, 0);">Reference Asset A: </font>120.00<font style="color: rgb(0, 0, 0);"> (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal to</font><font style="color: rgb(0, 0, 0);"> its Initial Level and Barrier Level)</font></div>
              <div style="margin-top: 3pt;"><font style="color: rgb(0, 0, 0);">Reference Asset B: </font>115.00<font style="color: rgb(0, 0, 0);"> (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal to</font><font style="color: rgb(0, 0, 0);"> its Initial Level and Barrier Level)</font></div>
            </td>
            <td style="width: 2.05%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" style="width: 34%; vertical-align: top;">
              <div style="margin: 3pt 0px 0px; color: #000000;"> <br>
              </div>
              <div style="margin: 3pt 0px 0px; color: #000000;">$1,000 (Principal Amount)</div>
              <div><font style="color: rgb(0, 0, 0);"><u>+ $</u></font><u>23.40</u><font style="color: rgb(0, 0, 0);"> (Contingent Interest Payment)</font></div>
              <div style="color: rgb(0, 0, 0);">$1,023.40 (Total Payment upon Automatic Call)</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 14%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom;">
              <div style="margin: 3pt 0px 0px; color: #000000; text-align: right;">Total Payment:</div>
            </td>
            <td style="width: 2.05%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" style="width: 34%; vertical-align: bottom;">
              <div style="margin: 6pt 0px 0px; color: #000000;">$1,023.40 (2.34% total return)</div>
            </td>
          </tr>

      </table>
      <div style="margin: 6pt 0px 0px; text-align: justify;">Because the Closing Level of each Reference Asset on the first Review Date is greater than or equal to its Initial Level (and therefore also greater than its Barrier Level), the Notes will be
        automatically called and, on the Call Payment Date, we will pay you a cash payment equal to $1,023.40 per Note, reflecting the Principal Amount plus the applicable Contingent Interest Payment, for a return of 2.34% per Note. No further amounts will
        be owed under the Notes.</div>
      <div style="text-align: justify; margin-top: 3pt;"> </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%;" id="z81acf3a2e439481f8e685310d7d8f79f" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 63pt;">
                <div style="text-align: justify; margin-top: 3pt;"><font style="font-weight: bold;">Example 2 &#8212;&#160; <br>
                  </font></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify; margin-top: 3pt;"><font style="font-weight: bold;">&#160;The Notes Are Automatically Called on the Third Call Payment Date.</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; margin-top: 3pt;"><font style="font-weight: bold;"> </font><br>
      </div>
      <div style="text-align: justify; margin-top: 3pt;"> </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td nowrap="nowrap" style="width: 14%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Review Date</div>
            </td>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Closing Levels</div>
            </td>
            <td style="width: 2.05%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" style="width: 34%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Payment (per Note)</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 14%; vertical-align: top;">
              <div style="margin-top: 3pt; color: rgb(0, 0, 0);">First</div>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="margin-top: 3pt; color: rgb(0, 0, 0);">Reference Asset A: 80.00 (<font style="font-weight: bold;">less than</font> its Initial Level; <font style="font-weight: bold;">greater than or equal to</font> its Barrier Level)</div>
              <div><font style="color: rgb(0, 0, 0);">Reference Asset B: 115.00 (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal to</font><font style="color: rgb(0, 0, 0);"> its Initial Level</font><font style="font-size: 12pt;">&#160;</font><font style="color: rgb(0, 0, 0);">and Barrier Level)</font></div>
            </td>
            <td style="width: 2.05%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" style="width: 34%; vertical-align: top;">
              <div style="margin-top: 3pt; color: rgb(0, 0, 0);">$23.40 (Contingent Interest Payment)</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 14%; vertical-align: top;">
              <div style="margin-top: 3pt; color: rgb(0, 0, 0);">Second</div>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="margin-top: 3pt; color: rgb(0, 0, 0);">Reference Asset A: 60.00 (<font style="font-weight: bold;">less than</font> its Initial Level and Barrier Level)</div>
              <div><font style="color: rgb(0, 0, 0);">Reference Asset B: 120.00 (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal to</font><font style="color: rgb(0, 0, 0);"> its Initial Level</font><font style="font-size: 12pt;">&#160;</font><font style="color: rgb(0, 0, 0);">and Barrier Level)</font></div>
            </td>
            <td style="width: 2.05%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" style="width: 34%; vertical-align: top;">
              <div style="margin-top: 3pt; color: rgb(0, 0, 0);">$0.00</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 14%; vertical-align: top;">
              <div style="margin-top: 3pt; color: rgb(0, 0, 0);">Third</div>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="margin-top: 3pt;"><font style="color: rgb(0, 0, 0);">Reference Asset A: </font>130.00<font style="color: rgb(0, 0, 0);"> (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal to</font><font style="color: rgb(0, 0, 0);"> its Initial Level and Barrier Level)</font></div>
              <div><font style="color: rgb(0, 0, 0);">Reference Asset B: </font>140.00<font style="color: rgb(0, 0, 0);"> (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal to</font><font style="color: rgb(0, 0, 0);"> its</font><font style="font-size: 12pt;">&#160;</font><font style="color: rgb(0, 0, 0);">Initial Level and Barrier Level)</font></div>
            </td>
            <td style="width: 2.05%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" style="width: 34%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">$1,000 (Principal Amount)</div>
              <div><font style="color: rgb(0, 0, 0);"><u>+ $</u></font><u>23.40</u><font style="color: rgb(0, 0, 0);"> (Contingent Interest Payment)</font></div>
              <div><font style="color: rgb(0, 0, 0);">$1,0</font>23.40<font style="color: rgb(0, 0, 0);"> (</font>Total<font style="color: rgb(0, 0, 0);"> Payment upon Automatic Call)</font></div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 14%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom;">
              <div style="text-align: right; color: rgb(0, 0, 0);">Total Payment:</div>
            </td>
            <td style="width: 2.05%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" style="width: 34%; vertical-align: bottom;">
              <div style="margin: 6pt 0px 0px; color: #000000;">$1,046.80 (4.68% total return)</div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt;">Because the Closing Level of at least one Reference Asset on the first Review Date is less than its Initial Level and the Closing Level of each Reference is greater than or equal to its Barrier
        Level, we will pay you the Contingent Interest Payment with respect to such Review Date on the corresponding Contingent Interest Payment Date. Because the Closing Level of a Reference Asset on the second Review Date is less than its Barrier Level,
        we will not pay a Contingent Interest Payment with respect to such Review Date on the corresponding Contingent Interest Payment Date. Because the Closing Level of each Reference Asset is greater than or equal to its Initial Level (and therefore
        also greater than its Barrier Level) on the third Review Date, the Notes will be automatically called and, on the Call Payment Date, we will pay you a cash payment equal to $1,023.40 per Note, reflecting the Principal Amount plus the Contingent
        Interest Payment with respect to such Review Date. When added to the Contingent Interest Payment of $22.30 paid in respect of the prior Contingent Interest Payment Dates, TD will have paid you a total of $1,046.80 per Note, for a return of 4.86%
        per Note.</div>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">9</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%;" id="z225dd34eee274e2fa6e79f2cea3be669" class="DSPFListTable">

              <tr style="vertical-align: top;">
                <td style="text-align: right; vertical-align: top; width: 63pt;">
                  <div style="font-weight: bold; text-align: left;">Example 3 &#8212;</div>
                </td>
                <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="font-weight: bold;">The Closing Level of each Reference Asset is greater than or equal to its Barrier Level on each of the Review Dates, the Notes Are Not Automatically Called and the Final Level of each Reference Asset is
                    Greater Than its Barrier Level.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div><br>
      </div>
      <div> </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td nowrap="nowrap" style="width: 14%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Review Date</div>
            </td>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Closing Levels</div>
            </td>
            <td style="width: 2.05%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" style="width: 34%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Payment (per Note)</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 14%; vertical-align: top;">
              <div style="margin-top: 3pt;"><font style="color: rgb(0, 0, 0);">First through</font></div>
              <div style="margin-top: 3pt;">Seventh</div>
            </td>
            <td style="width: 50%; vertical-align: top;">
              <div style="margin-top: 3pt; color: rgb(0, 0, 0);">Reference Asset A: Various (all <font style="font-weight: bold;">less than</font> its Initial Level and Barrier Level)</div>
              <div style="color: rgb(0, 0, 0);">Reference Asset B: Various (all <font style="font-weight: bold;">less than</font> its Initial Level; <font style="font-weight: bold;">greater than or equal to</font> its Barrier Level)</div>
            </td>
            <td style="width: 2.05%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" style="width: 34%; vertical-align: top;">
              <div style="margin-top: 3pt; color: rgb(0, 0, 0);">$0.00</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 14%; vertical-align: top;">
              <div style="margin-top: 3pt; color: rgb(0, 0, 0);">Final Review</div>
              <div style="margin-top: 3pt; color: rgb(0, 0, 0);">Date</div>
            </td>
            <td nowrap="nowrap" style="width: 50%; vertical-align: top;">
              <div style="margin-top: 3pt; color: rgb(0, 0, 0);">Reference Asset A: 80.00 (<font style="font-weight: bold;">greater than or equal to</font> its Barrier Level)</div>
              <div><font style="color: rgb(0, 0, 0);">Reference Asset B: </font>110.00<font style="color: rgb(0, 0, 0);"> (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal to</font><font style="color: rgb(0, 0, 0);"> its
                  Barrier Level)</font></div>
            </td>
            <td style="width: 2.05%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" style="width: 34%; vertical-align: bottom;">
              <div style="margin: 3pt 0px 0px; color: #000000;">$1,000 (Principal Amount)</div>
              <div><font style="color: rgb(0, 0, 0);"><u>+ $</u></font><u>23.40</u><font style="color: rgb(0, 0, 0);"> (Contingent Interest Payment)</font></div>
              <div><font style="color: rgb(0, 0, 0);">$1,0</font>23.40 <font style="color: rgb(0, 0, 0);">(Total Payment on Maturity Date)</font></div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 14%; vertical-align: bottom;">&#160;</td>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom;">
              <div style="text-align: right; color: rgb(0, 0, 0);">Total Payment:</div>
            </td>
            <td style="width: 2.05%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" style="width: 34%; vertical-align: bottom;">
              <div style="margin: 6pt 0px 0px;"><font style="color: rgb(0, 0, 0);">&#160;$</font>1,023.40 <font style="color: rgb(0, 0, 0);">(2.34% total return)</font></div>
            </td>
          </tr>

      </table>
      <div style="margin: 6pt 0px 0px; text-align: justify;"><font style="color: rgb(0, 0, 0);">Because the Closing Level </font>of at least one Reference Asset on each of <font style="color: rgb(0, 0, 0);">the Review Dates prior to the Final Review Date
          is less than its Initial Level and Barrier Level, we will not pay the Contingent Interest Payment on any of the corresponding Contingent Interest Payment Dates and the Notes will not be automatically called. Because the Final Level of each
          Reference Asset is greater than or equal to its Barrier Level on the Final Review Date, we will pay you a cash payment equal to $1,0</font>23.40<font style="color: rgb(0, 0, 0);"> per Note on the Maturity Date, reflecting the Principal Amount
          plus the applicable Contingent Interest Payment. </font>In this scenario, TD will have paid you a total of $1,023.40 per Note, for a return of 2.34% per Note.</div>
      <div style="text-align: justify; margin-top: 3pt;"> <br>
      </div>
      <div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: Arial; font-size: 9pt; width: 100%;" id="zbbbc26939fe34f0998b5ea34acb23dc5" class="DSPFListTable">

              <tr style="vertical-align: top;">
                <td style="text-align: right; vertical-align: top; width: 72pt;">
                  <div style="margin: 0px 0px 10pt; font-weight: bold; text-align: justify;">Example 4 &#8212;</div>
                </td>
                <td style="text-align: left; vertical-align: top; width: auto;">
                  <div style="margin: 0px 0px 10pt; font-weight: bold; text-align: justify;">The Closing Level of at least one Reference Asset is less than its Barrier Level on each of the Review Dates, the Notes Are Not Automatically Called and the Final
                    Level of the Least Performing Reference Asset is Less Than its Barrier Level.</div>
                </td>
              </tr>

          </table>
        </div>
      </div>
      <div></div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td nowrap="nowrap" style="width: 14%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Review Date</div>
            </td>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Closing Levels</div>
            </td>
            <td style="width: 2.05%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" style="width: 34%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0); font-weight: bold;">Payment (per Note)</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 14%; vertical-align: top;">
              <div style="margin-top: 3pt; color: rgb(0, 0, 0);">First through</div>
              <div style="margin-top: 3pt; color: rgb(0, 0, 0);">Seventh</div>
            </td>
            <td nowrap="nowrap" style="width: 50%; vertical-align: middle;">
              <div style="margin-top: 3pt; color: rgb(0, 0, 0);">Reference Asset A: Various (all <font style="font-weight: bold;">less than</font> its Initial Level and Barrier Level)</div>
              <div style="color: rgb(0, 0, 0);">Reference Asset B: Various (all <font style="font-weight: bold;">greater than or equal to</font> its Initial Level)</div>
            </td>
            <td style="width: 2.05%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" style="width: 34%; vertical-align: top;">
              <div style="color: rgb(0, 0, 0);">&#160;$0.00</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 14%; vertical-align: top;">
              <div style="margin-top: 3pt; color: rgb(0, 0, 0);">Final Review Date</div>
            </td>
            <td nowrap="nowrap" style="width: 50%; vertical-align: top;">
              <div style="margin-top: 3pt;"><font style="color: rgb(0, 0, 0);">Reference Asset A: </font>40.00<font style="color: rgb(0, 0, 0);"> (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">less than</font><font style="color: rgb(0, 0, 0);"> its Barrier Level)</font></div>
              <div><font style="color: rgb(0, 0, 0);">Reference Asset B: </font>115.00<font style="color: rgb(0, 0, 0);"> (</font><font style="font-weight: bold; color: rgb(0, 0, 0);">greater than or equal to</font><font style="color: rgb(0, 0, 0);"> its
                  Barrier Level)</font></div>
            </td>
            <td style="width: 2.05%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" style="width: 34%; vertical-align: bottom;">
              <div style="color: rgb(0, 0, 0);">= $1,000 + ($1,000 x Least Performing Percentage Change)</div>
              <div style="color: rgb(0, 0, 0);">= $1,000 + ($1,000 x -60.00%)</div>
              <div style="color: rgb(0, 0, 0);">= $400.00 (Total Payment on Maturity Date)</div>
            </td>
          </tr>
          <tr>
            <td nowrap="nowrap" style="width: 14%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" style="width: 50%; vertical-align: bottom;">
              <div style="text-align: right; color: rgb(0, 0, 0);">Total Payment:</div>
            </td>
            <td style="width: 2.05%; vertical-align: top;">&#160;</td>
            <td nowrap="nowrap" style="width: 34%; vertical-align: bottom;">
              <div style="margin: 6pt 0px 0px; color: #000000;">$400.00 (60.00% loss)</div>
            </td>
          </tr>

      </table>
      <div style="margin: 6pt 0px 0px; text-align: justify;"><font style="color: rgb(0, 0, 0);">Because the Closing Level </font>of at least one Reference Asset on <font style="color: rgb(0, 0, 0);">each of the Review Dates prior to the Final Review Date
          is less than its Initial Level and Barrier Level, we will not pay the Contingent Interest Payment on any of the corresponding Contingent Interest Payment Dates and the Notes will not be automatically called. Because the Final Level of the Least
          Performing Reference Asset is less than its Barrier Level, on the Final Review we will pay you a cash payment equal to the Principal Amount plus the product of the Principal Amount and the Least Performing Percentage Change, for a total of
          $400.00 per Note, a loss of 60.00% per Note.</font></div>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">10</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-top: 3pt;">The following table illustrates the hypothetical payments per Note that may be realized at maturity for a range of hypothetical Final Levels of the Least Performing Reference Asset, based on the
        hypothetical terms set forth above. The table assumes that the Notes have not been automatically called and does not reflect any Contingent Interest Payment that may be payable prior to the Maturity Date. The hypothetical returns set forth below
        are for illustrative purposes only and may not be the actual returns applicable to a purchaser of the Notes. The numbers appearing in the following table have been rounded for ease of analysis.</div>
      <table cellspacing="0" cellpadding="0" border="0" align="center" style="border-collapse: collapse; width: 80%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;" id="zd07f058511f64bfdac0a47331c669fb9">

          <tr>
            <td nowrap="nowrap" style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="margin: 3pt 0px 0px; font-weight: bold; text-align: center;">Hypothetical Final</div>
              <div style="font-weight: bold; text-align: center;">Level of Least</div>
              <div style="font-weight: bold; text-align: center;">Performing</div>
              <div style="margin: 0px 0px 3pt; font-weight: bold; text-align: center;">Reference Asset</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="margin: 3pt 0px 0px; font-weight: bold; text-align: center;">Hypothetical Least</div>
              <div style="font-weight: bold; text-align: center;">Performing</div>
              <div style="font-weight: bold; text-align: center;">Percentage Change</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Payment at Maturity</div>
            </td>
            <td nowrap="nowrap" style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="margin: 3pt 0px 0px; font-weight: bold; text-align: center;">Return on the</div>
              <div style="margin: 0px 0px 3pt; font-weight: bold; text-align: center;">Notes<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">140.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">40.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt;">$1,023.40</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">2.34%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">130.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">30.00%</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt;">$1,023.40</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">2.34%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">120.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">20.00%</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt;">$1,023.40</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">2.34%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">110.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">10.00%</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt;">$1,023.40</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">2.34%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">105.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">5.00%</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt;">$1,023.40</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">2.34%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; background-color: rgb(234, 241, 221); border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0); font-weight: bold;">100.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; background-color: rgb(234, 241, 221); border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0); font-weight: bold;">0.00%</div>
            </td>
            <td style="width: 20%; vertical-align: top; background-color: rgb(234, 241, 221); border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0); font-weight: bold;">$1,023.40</div>
            </td>
            <td style="width: 20%; vertical-align: top; background-color: rgb(234, 241, 221); border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0); font-weight: bold;">2.34%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">90.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-10.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$1,023.40</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">2.34%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">80.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-20.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$1,023.40</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">2.34%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; background-color: rgb(234, 241, 221); border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0); font-weight: bold;">70.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; background-color: rgb(234, 241, 221); border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0); font-weight: bold;">-30.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; background-color: rgb(234, 241, 221); border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0); font-weight: bold;">$1,023.40</div>
            </td>
            <td style="width: 20%; vertical-align: top; background-color: rgb(234, 241, 221); border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">2.34%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">60.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-40.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$600.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-40.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">50.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-50.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$500.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-50.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">40.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-60.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$400.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-60.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">30.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-70.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$300.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-70.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">20.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-80.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$200.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-80.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">10.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-90.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$100.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-90.00%</div>
            </td>
          </tr>
          <tr>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">0.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">-100.00%</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">$0.00</div>
            </td>
            <td style="width: 20%; vertical-align: middle; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; margin-bottom: 3pt; color: rgb(0, 0, 0);">0.00%</div>
            </td>
          </tr>
          <tr>
            <td colspan="4" rowspan="1" style="width: 20%; vertical-align: middle; border-top: 1px solid rgb(0, 0, 0);">
              <div style="text-align: justify;">
                <div style="margin: 2pt 0px 0px 18pt; text-indent: -18pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup>&#160; &#160; This column reflects the return received only in respect of the Payment at Maturity. In addition to this payment, if the Closing Level of each Reference Asset was
                  greater than or equal to its Barrier Level (but below its Initial Level) on one or more of the preceding Review Dates, investors would have previously received the applicable Contingent Interest Payment(s) on the corresponding Contingent
                  Interest Payment Date(s).</div>
              </div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">11</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-size: 16pt;">Information Regarding the Reference Assets</div>
      <div style="text-align: justify; margin-top: 6pt;">All disclosures contained in this document regarding the Reference Assets, including, without limitation, their make-up, methods of calculation, and changes in any Reference Asset Constituents, have
        been derived from publicly available sources. We have not undertaken an independent review or due diligence of any publicly available information with respect to any Reference Asset. The information reflects the policies of, and is subject to
        change by, the Index Sponsors. Each Index Sponsor owns the copyright and all other rights to the relevant Reference Asset, has no obligation to continue to publish, and may discontinue publication of, the relevant Reference Asset. None of the
        websites referenced in the Reference Asset descriptions below, or any materials included in those websites, are incorporated by reference into this document or any document incorporated herein by reference.</div>
      <div style="text-align: justify; margin-top: 6pt;">The graphs below set forth the information relating to the historical performance of each Reference Asset. The graphs below show the daily historical Closing Values of each Reference Asset for the
        periods specified. We obtained the information regarding the historical performance of each Reference Asset in the graphs below from Bloomberg.</div>
      <div style="margin: 6pt 0px; text-align: justify;">We have not independently verified the accuracy or completeness of the information obtained from Bloomberg. The historical performance of each Reference Asset should not be taken as an indication of
        its future performance, and no assurance can be given as to the Closing Level or Final Level of any Reference Asset on any Review Date. We cannot give you any assurance that the performance of the Reference Assets will result in a positive return
        on your initial investment.</div>
      <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; width: 5%; color: rgb(0, 0, 0); font-family: Arial; font-size: 9pt; text-align: left;" id="z16105f280b174dc2ac9406c35ceab6b5">

          <tr>
            <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="font-weight: bold; text-align: justify;">Dow Jones Industrial Average<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt;">We have derived all information regarding the Dow Jones Industrial Average<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (&#8220;INDU&#8221;) contained in this document, including, without limitation, its make-up, method of calculation and
        changes in its components, from publicly available information. Such information reflects the policies of, and is subject to change by S&amp;P Dow Jones Indices LLC (its &#8220;Index Sponsor&#8221; or &#8220;S&amp;P Dow Jones&#8221;).</div>
      <div style="text-align: justify; margin-top: 6pt;">INDU is published by S&amp;P Dow Jones, but S&amp;P Dow Jones has no obligation to continue to publish INDU, and may discontinue publication of INDU at any time. INDU is determined, comprised and
        calculated by S&amp;P Dow Jones without regard to this instrument.</div>
      <div style="text-align: justify; margin-top: 6pt;">As discussed more fully in the underlier supplement under the heading &#8220;Indices &#8212; The Dow Jones Industrial Average<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>&#8221;, INDU is a price-weighted index composed of 30 U.S. blue-chip companies
        selected at the discretion of the Averages Committee, which is comprised of three representatives of S&amp;P Dow Jones and two representatives of The Wall Street Journal. While INDU component selection is not governed by quantitative rules, the
        Averages Committee selects the INDU components based on the company&#8217;s reputation, growth and interest to investors. Maintaining adequate sector representation is also a consideration in the selection process. INDU covers all industries with the
        exception of transportation and utilities. The Averages Committee may revise index policy covering rules for selecting companies, treatment of dividends, share counts or other matters.</div>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">12</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-bottom: 6pt; font-weight: bold;">Historical Information</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The graph below illustrates the performance of the Reference Asset from March 5, 2015 through March 5, 2025. The dotted line represents its Barrier Level of 30,104.613, which is equal to 70.00% of
        the Initial Level.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">We obtained the information regarding the historical performance of the Reference Asset in the graph below from Bloomberg.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">We have not independently verified the accuracy or completeness of the information obtained from Bloomberg. The historical performance of the Reference Asset should not be taken as an indication
        of its future performance, and no assurance can be given as to the Closing Level of the Reference Asset on any Review Date or that the performance of the Reference Asset will result in a positive return on your initial investment.</div>
      <div style="margin: 0px 0px 8pt; font-size: 12pt; font-weight: bold; text-align: center; text-indent: 4.5pt;">Dow Jones Industrial Average<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (INDU)</div>
      <div style="margin: 0px 0px 8pt; text-align: center;"><img src="image3.jpg"></div>
      <div style="text-align: center; font-style: italic; font-weight: bold;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
      <div style="font-style: normal; font-weight: 400;"> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">13</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; width: 5%; color: rgb(0, 0, 0); font-family: Arial; font-size: 9pt; text-align: left;" id="z2b338e7c3b4a46a99b9268a9142176a6">

          <tr>
            <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">
              <div style="font-weight: bold; text-align: justify;">Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
            </td>
          </tr>

      </table>
      <div style="text-align: justify; margin-top: 6pt;">We have derived all information regarding the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (&#8220;NDX&#8221;) contained in this document, including, without limitation, its make-up, method of calculation and changes in its
        components, from publicly available information. Such information reflects the policies of, and is subject to change by Nasdaq, Inc. and its affiliates (collectively, &#8220;Nasdaq&#8221;) (its &#8220;Index Sponsor&#8221; or &#8220;Nasdaq&#8221;).</div>
      <div style="text-align: justify; margin-top: 6pt;">NDX is published by Nasdaq, but Nasdaq has no obligation to continue to publish NDX, and may discontinue publication of NDX at any time. NDX is determined, comprised and calculated by Nasdaq without
        regard to this instrument.</div>
      <div style="text-align: justify; margin-top: 6pt;">As discussed more fully in the underlier supplement under the heading &#8220;Indices &#8212; Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>&#8221;, NDX includes 100 of the largest domestic and international non-financial securities
        listed on the Nasdaq Stock Market<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> based on market capitalization. NDX includes companies across major industry groups including computer hardware and software, telecommunications, retail and wholesale trade, and biotechnology, but does
        not contain securities of financial companies, including investment companies.</div>
      <div><br>
      </div>
      <div style="text-align: justify;">NDX is calculated under a modified capitalization-weighted methodology. The methodology is expected to retain in general the economic attributes of capitalization-weighting while providing enhanced diversification.
        To accomplish this, Nasdaq will review the composition of NDX on a quarterly basis and adjust the weightings of Index components using a proprietary algorithm, if certain pre-established weight distribution requirements are not met.</div>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">14</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="margin-bottom: 6pt; font-weight: bold;">Historical Information</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The graph below illustrates the performance of the Reference Asset from March 5, 2015 through March 5, 2025. The dotted line represents its Barrier Level of 14,439.922, which is equal to 70.00% of
        the Initial Level.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">We obtained the information regarding the historical performance of the Reference Asset in the graph below from Bloomberg.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">We have not independently verified the accuracy or completeness of the information obtained from Bloomberg. The historical performance of the Reference Asset should not be taken as an indication
        of its future performance, and no assurance can be given as to the Closing Level of the Reference Asset on any Review Date or that the performance of the Reference Asset will result in a positive return on your initial investment.</div>
      <div style="margin: 0px 0px 8pt; font-size: 10pt; font-weight: bold; text-align: center; text-indent: 4.5pt;">Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (NDX)</div>
      <div style="margin: 0px 0px 8pt; text-align: center;"><img src="image4.jpg"></div>
      <div style="text-align: center; font-style: italic; font-weight: bold;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
      <div style="font-style: normal; font-weight: 400;"> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">15</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-size: 16pt;">Material U.S. Federal Income Tax Consequences</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The U.S. federal income tax consequences of your investment in the Notes are uncertain. No statutory, regulatory, judicial or administrative authority directly discusses how the
        Notes should be treated for U.S. federal income tax purposes. Some of these tax consequences are summarized below, but we urge you to read the more detailed discussion under &#8220;Material U.S. Federal Income Tax Consequences&#8221; in the product supplement
        and discuss the tax consequences of your particular situation with your tax advisor. This discussion is based upon the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), final, temporary and proposed U.S. Department of the Treasury (the
        &#8220;Treasury&#8221;) regulations, rulings and decisions, in each case, as available and in effect as of the date hereof, all of which are subject to change, possibly with retroactive effect. Tax consequences under state, local and non-U.S. laws are not
        addressed herein. No ruling from the U.S. Internal Revenue Service (the &#8220;IRS&#8221;) has been sought as to the U.S. federal income tax consequences of your investment in the Notes, and the following discussion is not binding on the IRS. Except as
        discussed under the heading &#8220;Non-U.S. Holders&#8221;, this discussion is applicable only to a U.S. holder that acquires Notes upon initial issuance and holds its Notes as a capital asset for U.S. federal income tax purposes.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">U.S. Tax Treatment.</font> Pursuant to the terms of the Notes, TD and you agree, in the absence of a statutory or regulatory change or an administrative
        determination or judicial ruling to the contrary, to characterize your Notes as prepaid derivative contracts with respect to the Reference Assets. Pursuant to this treatment, any Contingent Interest Payments paid on the Notes (including any
        Contingent Interest Payments paid on or with respect to the Maturity Date) would be treated as ordinary income includable in income by you in accordance with your regular method of accounting for U.S. federal income tax purposes. Holders are urged
        to consult their tax advisors concerning the significance, and the potential impact, of the above considerations. If your Notes are so treated, upon the taxable disposition (including cash settlement) of a Note, you generally should recognize gain
        or loss in an amount equal to the difference between the amount realized on such taxable disposition (adjusted for accrued and unpaid Contingent Interest Payments treated as ordinary income) and your tax basis in the Note. Your tax basis in a Note
        generally should equal your cost for the Note. Such gain or loss should generally be long-term capital gain or loss if you have held your Notes for more than one year (otherwise such gain or loss should be short-term capital gain or loss if held
        for one year or less). The deductibility of capital losses is subject to limitations. Although uncertain, it is possible that proceeds received from the sale or exchange of your Notes prior to a Review Date, but that could be attributed to an
        expected Contingent Interest Payment, could be treated as ordinary income. You should consult your tax advisor regarding this risk.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Based on certain factual representations received from us, our special U.S. tax counsel, Fried, Frank, Harris, Shriver, &amp; Jacobson LLP is of the opinion that it would be
        reasonable to treat your Notes in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the Notes, it is possible that your Notes could alternatively be treated for tax purposes as a
        single contingent payment debt instrument, or pursuant to some other characterization, such that the timing and character of your income from the Notes could differ materially and adversely from the treatment described above, as described further
        under &#8220;Material U.S. Federal Income Tax Consequences &#8212; Alternative Treatments&#8221; in the product supplement.</div>
      <div style="text-align: justify; margin-top: 6pt;">Except to the extent otherwise required by law, TD intends to treat your Notes for U.S. federal income tax purposes in accordance with the treatment described above and under &#8220;Material U.S. Federal
        Income Tax Consequences&#8221; of the product supplement, unless and until such time as the Treasury and the IRS determine that some other treatment is more appropriate.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Section 1297</font>. We will not attempt to ascertain whether any Reference Asset Constituent Issuer would be treated as a &#8220;passive foreign investment company&#8221; (a
        &#8220;PFIC&#8221;) within the meaning of Section 1297 of the Code. If any such entity were so treated, certain adverse U.S. federal income tax consequences might apply upon the taxable disposition of a Note. You should refer to information filed with the SEC
        or the equivalent governmental authority by such entities and consult your tax advisor regarding the possible consequences to you if any such entity is or becomes a PFIC.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Notice 2008-2. </font>In 2007, the IRS released a notice that may affect the taxation of holders of the Notes. According to Notice 2008-2, the IRS and the Treasury
        are actively considering whether the holder of an instrument such as the Notes should be required to accrue ordinary income on a current basis. It is not possible to determine what guidance they will ultimately issue, if any. It is possible,
        however, that under such guidance, holders of the Notes will ultimately be required to accrue current income in excess of any receipt of Contingent Interest Payments and this could be applied on a retroactive basis. The IRS and the Treasury are
        also considering other relevant issues, including whether additional gain or loss from such instruments should be treated as ordinary or capital, and whether the special &#8220;constructive ownership rules&#8221; of Section 1260 of the Code should be applied
        to such instruments. Both U.S. and non-U.S. holders are urged to consult their tax advisors concerning the significance and potential impact of the above considerations.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Medicare Tax on Net Investment Income.</font> U.S. holders that are individuals, estates or certain trusts are subject to an additional 3.8% tax on all or a portion
        of their &#8220;net investment income,&#8221; or &#8220;undistributed net investment income&#8221; in the case of an estate or trust, which may include any income or gain realized with respect to the Notes, to the extent of their net investment income or undistributed net
        investment income (as the case may be) that, when added to their other modified adjusted gross income, exceeds $200,000 for an unmarried individual, $250,000 for a married taxpayer filing a joint return (or a surviving spouse), $125,000 for a
        married individual filing a separate return or the dollar amount at which the highest tax bracket begins for an estate or trust. The 3.8% Medicare tax is determined in a different manner than the regular income tax. U.S. holders should consult
        their tax advisors as to the consequences of the 3.8% Medicare tax.</div>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">16</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="font-style: italic;">Specified Foreign Financial Assets.</font> U.S. holders may be subject to reporting obligations with respect to their Notes if they do not hold their Notes in an account maintained
        by a financial institution and the aggregate value of their Notes and certain other &#8220;specified foreign financial assets&#8221; (applying certain attribution rules) exceeds an applicable threshold. Significant penalties can apply if a U.S. holder is
        required to disclose its Notes and fails to do so.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Backup Withholding and Information Reporting. </font>The proceeds received from a taxable disposition of the Notes will be subject to information reporting unless
        you are an &#8220;exempt recipient&#8221; and may also be subject to backup withholding at the rate specified in the Code if you fail to provide certain identifying information (such as an accurate taxpayer number, if you are a U.S. holder) or meet certain
        other conditions.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Non-U.S. Holders</font>. The U.S. federal income tax treatment of the Contingent Interest Payments is unclear.<font style="font-size: 10pt;">&#160;</font><font style="font-weight: bold;">Accordingly, we will treat any Contingent Interest Payments on the Notes as subject to a 30% U.S. withholding tax. To the extent we have withholding responsibilities with respect to a Note, we intend to withhold such
          tax on any Contingent Interest Payment and we anticipate that other withholding agents would do the same.</font>&#160;<font style="font-weight: bold;">You are urged to consult your tax advisors regarding the application of the withholding tax to your
          Notes and the availability of any reduction in tax pursuant to an income tax treaty. No assurance can be given that you will be able to successfully claim a reduction in tax pursuant to an applicable income tax treaty. We will not pay any
          additional amounts in respect of any such withholding.</font></div>
      <div style="text-align: justify; margin-top: 6pt;">If you are a non&#8209;U.S. holder, you should provide us (and/or the applicable withholding agent) with a fully completed and validly executed applicable IRS Form W&#8209;8. Subject to Section 897 of the Code
        and Section 871(m) of the Code, discussed herein, gain realized from the taxable disposition of the Notes (other than amounts or proceeds attributable to a Contingent Interest Payment or any accrued but unpaid Contingent Interest Payment) generally
        should not be subject to U.S. tax unless (i) such gain is effectively connected with a trade or business conducted by the non&#8209;U.S. holder in the U.S., (ii) the non&#8209;U.S. holder is a non&#8209;resident alien individual and is present in the U.S. for 183
        days or more during the taxable year of such taxable disposition and certain other conditions are satisfied or (iii) the non&#8209;U.S. holder has certain other present or former connections with the U.S.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Section 897</font>. We will not attempt to ascertain whether any Reference Asset Constituent Issuer would be treated as a &#8220;United States real property holding
        corporation&#8221; (&#8220;USRPHC&#8221;) within the meaning of Section 897 of the Code. We also have not attempted to determine whether the Notes should be treated as &#8220;United States real property interests&#8221; (&#8220;USRPI&#8221;) as defined in Section 897 of the Code. If any
        such entity and the Notes were so treated, certain adverse U.S. federal income tax consequences could possibly apply, including subjecting any gain to a non-U.S. holder in respect of a Note upon a taxable disposition of a Note to the U.S. federal
        income tax on a net basis and the gross proceeds from such a taxable disposition could be subject to a 15% withholding tax. Non-U.S. holders should consult their tax advisors regarding the potential treatment of any such entity as a USRPHC and the
        Notes as USRPI.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Section 871(m)</font>. A 30% withholding tax (which may be reduced by an applicable income tax treaty) is imposed under Section 871(m) of the Code on certain
        &#8220;dividend equivalents&#8221; paid or deemed paid to a non-U.S. holder with respect to a &#8220;specified equity-linked instrument&#8221; that references one or more dividend-paying U.S. equity securities or indices containing U.S. equity securities. The withholding
        tax can apply even if the instrument does not provide for payments that reference dividends. Treasury regulations provide that the withholding tax applies to all dividend equivalents paid or deemed paid on specified equity-linked instruments that
        have a delta of one (&#8220;delta-one specified equity-linked instruments&#8221;) issued after 2016 and to all dividend equivalents paid or deemed paid on all other specified equity-linked instruments issued after 2017. However, the IRS has issued guidance
        that states that the Treasury and the IRS intend to amend the effective dates of the Treasury regulations to provide that withholding on dividend equivalents paid or deemed paid will not apply to specified equity-linked instruments that are not
        delta-one specified equity-linked instruments and are issued before January 1, 2027.</div>
      <div style="text-align: justify; margin-top: 6pt;">Based on the nature of the Reference Asset and our determination that the Notes are not &#8220;delta-one&#8221; with respect to any Reference Asset or any Reference Asset Constituent, our special U.S. tax
        counsel is of the opinion that the Notes should not be delta-one specified equity-linked instruments and thus should not be subject to withholding on dividend equivalents. Our determination is not binding on the IRS, and the IRS may disagree with
        this determination. Furthermore, the application of Section 871(m) of the Code will depend on our determinations on the date the terms of the Notes are set. If withholding is required, we will not make payments of any additional amounts.</div>
      <div style="text-align: justify; margin-top: 6pt;">Nevertheless, after the date the terms are set, it is possible that your Notes could be deemed to be reissued for tax purposes upon the occurrence of certain events affecting a Reference Asset, any
        Reference Asset Constituent or your Notes, and following such occurrence your Notes could be treated as delta-one specified equity-linked instruments that are subject to withholding on dividend equivalents. It is also possible that withholding tax
        or other tax under Section 871(m) of the Code could apply to the Notes under these rules if you enter, or have entered, into certain other transactions in respect of a Reference Asset, any Reference Asset Constituent or the Notes. If you enter, or
        have entered, into other transactions in respect of a Reference Asset, any Reference Asset Constituent or the Notes, you should consult your tax advisor regarding the application of Section 871(m) of the Code to your Notes in the context of your
        other transactions.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Because of the uncertainty regarding the application of the 30% withholding tax on dividend equivalents to the Notes, you are urged to consult your tax advisor regarding the
        potential application of Section 871(m) of the Code and the 30% withholding tax to an investment in the Notes.</div>
      <div style="text-align: justify; margin-top: 6pt;">U.S. Federal Estate Tax Treatment of Non-U.S. Holders. A Note may be subject to U.S. federal estate tax if an individual non-U.S. holder holds the Note at the time of his or her death. The gross
        estate of a non-U.S. holder domiciled outside the U.S. includes only property situated in the U.S. Individual non-U.S. holders should consult their tax advisors regarding the U.S. federal estate tax consequences of holding the Notes at death.</div>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">17</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify;"><font style="font-style: italic;">Foreign Account Tax Compliance Act. </font>The Foreign Account Tax Compliance Act (&#8220;FATCA&#8221;) was enacted on March 18, 2010, and imposes a 30% U.S. withholding tax on &#8220;withholdable
        payments&#8221; (i.e., certain U.S.-source payments, including interest (and original issue discount), dividends, other fixed or determinable annual or periodical income, and the gross proceeds from a disposition of property of a type that can produce
        U.S.-source interest or dividends) and &#8220;passthru payments&#8221; (i.e., certain payments attributable to withholdable payments) made to certain foreign financial institutions (and certain of their affiliates) unless the payee foreign financial
        institution agrees (or is required), among other things, to disclose the identity of any U.S. individual with an account at the institution (or the relevant affiliate) and to annually report certain information about such account. FATCA also
        requires withholding agents making withholdable payments to certain foreign entities that do not disclose the name, address, and taxpayer identification number of any substantial U.S. owners (or do not certify that they do not have any substantial
        U.S. owners) to withhold tax at a rate of 30%. Under certain circumstances, a holder may be eligible for refunds or credits of such taxes.</div>
      <div style="text-align: justify; margin-top: 6pt;">Pursuant to final and temporary Treasury regulations and other IRS guidance, the withholding and reporting requirements under FATCA will generally apply to certain &#8220;withholdable payments&#8221;, will not
        apply to gross proceeds on a sale or disposition, and will apply to certain foreign passthru payments only to the extent that such payments are made after the date that is two years after final regulations defining the term &#8220;foreign passthru
        payment&#8221; are published. If withholding is required, we (or the applicable paying agent) will not be required to pay additional amounts with respect to the amounts so withheld. Foreign financial institutions and non-financial foreign entities
        located in jurisdictions that have an intergovernmental agreement with the U.S. governing FATCA may be subject to different rules.</div>
      <div style="text-align: justify; margin-top: 6pt;">Investors should consult their tax advisors about the application of FATCA, in particular if they may be classified as financial institutions (or if they hold their Notes through a foreign entity)
        under the FATCA rules.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Proposed Legislation</font>. In 2007, legislation was introduced in Congress that, if it had been enacted, would have required holders of Notes purchased after the
        bill was enacted to accrue interest income over the term of the Notes despite the fact that there may be no interest payments over the term of the Notes.</div>
      <div style="text-align: justify; margin-top: 6pt;">Furthermore, in 2013, the House Ways and Means Committee released in draft form certain proposed legislation relating to financial instruments. If it had been enacted, the effect of this legislation
        generally would have been to require instruments such as the Notes to be marked to market on an annual basis with all gains and losses to be treated as ordinary, subject to certain exceptions.</div>
      <div style="text-align: justify; margin-top: 6pt;">It is impossible to predict whether any similar or identical bills will be enacted in the future, or whether any such bill would affect the tax treatment of your Notes. You are urged to consult your
        tax advisor regarding the possible changes in law and their possible impact on the tax treatment of your Notes.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">You are urged to consult your tax advisor concerning the application of U.S. federal income tax laws to an investment in the Notes, as well as any tax consequences of the purchase,
        beneficial ownership and disposition of the Notes arising under the laws of any state, local, non-U.S. or other taxing jurisdiction (including that of TD and those of the Reference Asset Constituent Issuers).</div>
      <div style="font-weight: 400;"> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">18</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 10pt; color: rgb(0, 176, 80); font-size: 16pt;">Supplemental Plan of Distribution (Conflicts of Interest)</div>
      <div style="text-align: justify; margin-top: 6pt;">We have appointed TDS, an affiliate of TD, as the Agent for the sale of the Notes. Pursuant to the terms of a distribution agreement, TDS will purchase the Notes from TD at the public offering price
        less a concession equal to the underwriting discount set forth on the cover page of this pricing supplement. J.P. Morgan Securities LLC , which we refer to as JPMS LLC, and JPMorgan Chase Bank, N.A. will act as placement agents for the Notes and,
        from the commission to TDS, will receive a placement fee of $7.50 for each Note they sell in this offering to accounts other than fiduciary accounts. TDS and the placement agents will forgo a commission and placement fee for sales to fiduciary
        accounts.</div>
      <div style="text-align: justify; margin-top: 6pt;">TD will reimburse TDS for certain expenses in connection with its role in the offer and sale of the Notes, and TD will pay TDS a fee in connection with its role in the offer and sale of the Notes.
        Additionally, we or one of our affiliates will pay a fee to an unaffiliated broker-dealer for providing certain electronic platform services with respect to this offering.</div>
      <div style="text-align: justify; margin-top: 6pt;">For the avoidance of doubt, the fees and commissions described on the cover of this pricing supplement will not be rebated or subject to amortization if the Notes are automatically called.</div>
      <div style="text-align: justify; margin-top: 6pt;">Delivery of the Notes will be made against payment therefor on the Issue Date, which is the third DTC settlement day following the Pricing Date. Under Rule 15c6-1 of the Exchange Act, trades in the
        secondary market generally are required to settle in one DTC settlement day (&#8220;T+1&#8221;), unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes in the secondary market on any date prior to one DTC
        settlement day before delivery of the Notes will be required, by virtue of the fact that each Note initially will settle in three DTC settlement days (&#8220;T+3&#8221;), to specify alternative settlement arrangements to prevent a failed settlement of the
        secondary market trade.</div>
      <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Conflicts of Interest. </font>TDS is an affiliate of TD and, as such, has a &#8220;conflict of interest&#8221; in this offering within the meaning of Financial Industry
        Regulatory Authority, Inc. (&#8220;FINRA&#8221;) Rule 5121. In addition, TD will receive the net proceeds from the initial public offering of the Notes, thus creating an additional conflict of interest within the meaning of FINRA Rule 5121. This offering of
        the Notes will be conducted in compliance with the provisions of FINRA Rule 5121. In accordance with FINRA Rule 5121, neither TDS nor any other affiliated agent of ours is permitted to sell the Notes in this offering to an account over which it
        exercises discretionary authority without the prior specific written approval of the account holder.</div>
      <div style="text-align: justify; margin-top: 6pt;">We, TDS, another of our affiliates or third parties may use this pricing supplement and any document incorporated herein by reference in the initial sale of the Notes. In addition, we, TDS, another
        of our affiliates or third parties may use this pricing supplement and any document incorporated herein by reference in a market-making transaction in the Notes after their initial sale. <font style="font-weight: bold; font-style: italic;">If a
          purchaser buys the Notes from us, TDS, another of our affiliates or a third party, this pricing supplement is being used in a market-making transaction unless we, TDS, another of our affiliates or such third party informs such purchaser otherwise
          in the confirmation of sale.</font></div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Prohibition on Sales to EEA Retail Investors</div>
      <div style="text-align: justify; margin-top: 6pt;">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area (the
        &#8220;EEA&#8221;). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, &#8220;MiFID II&#8221;); (ii) a customer within the meaning of Directive
        (EU) 2016/97, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Regulation (EU) 2017/1129, as amended. Consequently no key
        information document required by Regulation (EU) No 1286/2014 (the &#8220;EU PRIIPs Regulation&#8221;) for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the
        Notes or otherwise making them available to any retail investor in the EEA may be unlawful under the EU PRIIPs Regulation.</div>
      <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Prohibition on Sales to United Kingdom Retail Investors</div>
      <div style="text-align: justify; margin-top: 6pt;">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the United Kingdom (&#8220;UK&#8221;). For
        these purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act
        2018 (the &#8220;EUWA&#8221;); or (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (the &#8220;FSMA&#8221;) and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that customer would
        not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA. Consequently no key information document required by Regulation (EU) No 1286/2014
        as it forms part of domestic law by virtue of the EUWA (the &#8220;UK PRIIPs Regulation&#8221;) for offering or selling the Notes or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling the Notes or
        otherwise making them available to any retail investor in the UK may be unlawful under the UK PRIIPs Regulation.</div>
      <div> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">19</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 8pt; color: rgb(0, 176, 80); font-size: 16pt;">Additional Information Regarding the Estimated Value of the Notes</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The final terms for the Notes were determined on the Strike Date, based on prevailing market conditions, and are set forth in this pricing supplement.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">The economic terms of the Notes are based on our internal funding rate (which is our internal borrowing rate based on variables such as market benchmarks and our appetite for borrowing), and
        several factors, including any sales commissions expected to be paid to TDS or another affiliate of ours, any selling concessions, discounts, commissions or fees expected to be allowed or paid to non-affiliated intermediaries, the estimated profit
        that we or any of our affiliates expect to earn in connection with structuring the Notes, estimated costs which we may incur in connection with the Notes and the estimated cost which we may incur in hedging our obligations under the Notes. Because
        our internal funding rate generally represents a discount from the levels at which our benchmark debt securities trade in the secondary market, the use of an internal funding rate for the Notes rather than the levels at which our benchmark debt
        securities trade in the secondary market is expected to have had an adverse effect on the economic terms of the Notes.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">On the cover page of this pricing supplement, we have provided the estimated value for the Notes. The estimated value was determined by reference to our internal pricing models which take into
        account a number of variables and are based on a number of assumptions, which may or may not materialize, typically including volatility, interest rates (forecasted, current and historical rates), price-sensitivity analysis, time to maturity of the
        Notes, and our internal funding rate. For more information about the estimated value, see &#8220;Additional Risk Factors&#8221; herein. Because our internal funding rate generally represents a discount from the levels at which our benchmark debt securities
        trade in the secondary market, the use of an internal funding rate for the Notes rather than the levels at which our benchmark debt securities trade in the secondary market is expected, assuming all other economic terms are held constant, to
        increase the estimated value of the Notes. For more information see the discussion under &#8220;Additional Risk Factors &#8212; Risks Relating to Estimated Value and Liquidity &#8212; The Estimated Value of Your Notes Is Based on Our Internal Funding Rate.&#8221;</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Our estimated value of the Notes is not a prediction of the price at which the Notes may trade in the secondary market, nor will it be the price at which the Agent may buy or sell the Notes in the
        secondary market. Subject to normal market and funding conditions, the Agent or another affiliate of ours intends to offer to purchase the Notes in the secondary market but it is not obligated to do so.</div>
      <div style="text-align: justify; margin-bottom: 6pt;">Assuming that all relevant factors remain constant after the Pricing Date, the price at which the Agent may initially buy or sell the Notes in the secondary market, if any, may exceed our
        estimated value on the Pricing Date for a temporary period expected to be approximately 3 months after the Issue Date because, in our discretion, we may elect to effectively reimburse to investors a portion of the estimated cost of hedging our
        obligations under the Notes and other costs in connection with the Notes which we will no longer expect to incur over the term of the Notes. We made such discretionary election and determined this temporary reimbursement period on the basis of a
        number of factors, including the tenor of the Notes and any agreement we may have with the distributors of the Notes. The amount of our estimated costs which we effectively reimburse to investors in this way may not be allocated ratably throughout
        the reimbursement period, and we may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the Issue Date of the Notes based on changes in market conditions and other factors that cannot be predicted.</div>
      <div style="font-weight: bold; text-align: justify;">We urge you to read the &#8220;Additional Risk Factors&#8221; beginning on page P-3 of this pricing supplement.</div>
      <div style="font-weight: 400;"> <br>
      </div>
      <div style="clear: both; margin-top: 9pt; margin-bottom: 9pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
                </td>
                <td style="width: 50.00%;">
                  <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">20</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; margin-bottom: 8pt; color: rgb(0, 176, 80); font-size: 16pt;">Validity of the Notes</div>
      <div style="text-align: justify; margin-bottom: 10pt;">In the opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP, as special products counsel to TD, when the Notes offered by this pricing supplement have been executed and issued by TD and
        authenticated by the trustee pursuant to the indenture and delivered, paid for and sold as contemplated herein, the Notes will be valid and binding obligations of TD, enforceable against TD in accordance with their terms, subject to applicable
        bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium, receivership or other laws relating to or affecting creditors&#8217; rights generally, and to general principles of equity (regardless of whether enforcement is sought in a
        proceeding at law or in equity). This opinion is given as of the date hereof and is limited to the laws of the State of New York. Insofar as this opinion involves matters governed by Canadian law, Fried, Frank, Harris, Shriver &amp; Jacobson LLP
        has assumed, without independent inquiry or investigation, the validity of the matters opined on by McCarthy T&#233;trault LLP, Canadian legal counsel for TD, in its opinion expressed below. In addition, this opinion is subject to customary assumptions
        about the trustee&#8217;s authorization, execution and delivery of the indenture and, with respect to the Notes, authentication of the Notes and the genuineness of signatures and certain factual matters, all as stated in the opinion of Fried, Frank,
        Harris, Shriver &amp; Jacobson LLP filed as Exhibit 5.3 to the registration statement on Form F-3 filed by TD on December 20, 2024.</div>
      <div style="text-align: justify;">In the opinion of McCarthy T&#233;trault LLP, the issue and sale of the Notes has been duly authorized by all necessary corporate action on the part of TD, and when this pricing supplement has been attached to, and duly
        notated on, the master note that represents the Notes, the Notes will have been validly executed and issued and, to the extent validity of the Notes is a matter governed by the laws of the Province of Ontario, or the laws of Canada applicable
        therein, will be valid obligations of TD, subject to the following limitations: (i) the enforceability of the indenture is subject to bankruptcy, insolvency, reorganization, arrangement, winding up, moratorium and other similar laws of general
        application limiting the enforcement of creditors&#8217; rights generally; (ii) the enforceability of the indenture is subject to general equitable principles, including the fact that the availability of equitable remedies, such as injunctive relief and
        specific performance, is in the discretion of a court; (iii) courts in Canada are precluded from giving a judgment in any currency other than the lawful money of Canada; and (iv) the enforceability of the indenture will be subject to the
        limitations contained in the Limitations Act, 2002 (Ontario), and such counsel expresses no opinion as to whether a court may find any provision of the indenture to be unenforceable as an attempt to vary or exclude a limitation period under that
        Act. This opinion is given as of the date hereof and is limited to the laws of the Province of Ontario and the federal laws of Canada applicable thereto. In addition, this opinion is subject to: (i) the assumption that the senior indenture has been
        duly authorized, executed and delivered by, and constitutes a valid and legally binding obligation of, the trustee, enforceable against the trustee in accordance with its terms; and (ii) customary assumptions about the genuineness of signatures and
        certain factual matters all as stated in the letter of such counsel dated December 20, 2024, which has been filed as Exhibit 5.2 to the registration statement on Form F-3 filed by TD on December 20, 2024.</div>
      <div><br>
      </div>
      <div><br>
      </div>
    </div>
    <div>
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 50.00%;">
                <div style="font-size: 8pt; text-align: left;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50.00%;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">21</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>exfilingfees.htm
<DESCRIPTION>EXHIBIT 107.1
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Fri Mar 07 05:41:29 UTC 2025 -->
<!--?xml version="1.0" encoding="ASCII"?-->
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Mar 04 23:02:01 UTC 2025 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title> </title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc. Document created using Broadridge PROfile 25.1.1.5279 Copyright 1995 - 2025 Broadridge -->



<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font-family: Arial; font-size: 9pt; text-align: left; color: rgb(0, 0, 0);"><div>
    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-bottom: 20px;">

      <div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;">Calculation of Filing Fee Tables</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;"><ix:nonNumeric contextRef="c0" name="ffd:FormTp" id="ixv-31">F-3</ix:nonNumeric></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-32">TORONTO DOMINION BANK</ix:nonNumeric></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 12pt; font-weight: bold;">Narrative Disclosure</div>
        <div style="text-align: center; font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>

        <ix:nonNumeric contextRef="c0" escape="true" name="ffd:NrrtvDsclsr" id="ixv-26"><div style="text-align: center; font-family: Arial; font-size: 12pt;">The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ffd:NrrtvMaxAggtOfferingPric" scale="0" unitRef="usd" id="ixv-33">500,000</ix:nonFraction>. The prospectus is a <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ffd:FnlPrspctsFlg" id="ixv-34">final prospectus</ix:nonNumeric> for the related offering.</div></ix:nonNumeric><div><br/>
        </div>
      </div>
    </div>
  </div></div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-37">0000947263</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:FeeExhibitTp" id="ixv-38">EX-FILING FEES</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:RegnFileNb" id="ixv-39">333-283969</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:SubmissnTp" id="ixv-40">424B2</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context xmlns="" id="c0">
<!-- [WMV6][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt9uqgO9qQHmt9BQ98lPQIyw5e87n1ClNcn+HKOKf3z5APYPsa854hyILWuQ1G+ix7+VamOL3Zs42uLWL00PhFvbkcPGoylrq23MpAK0o4ffBxJ4tb4WfmDVs7XtyyM552rCefDBgn6ZDBroX4nYLHDC6G3mHGwdCFQKU25W8frJwalZj+cZSapM/2VBJLrxrffaZWVYPC54AlxaFhC/kyyBSktvd3tLVXZ2mIyqM3GSL6URpMaQWQs8kDoNoP4WMm6AQNtMZYg8HkW4esTQNNZol6/eS8JuyslE8Iz8oLaE0POHLGlPjNd2vPXPhPSORo9Hk/70YDBRzf97HwMk/NUqyTYfby36gZA=] CSR-->
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000947263</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-03-06</xbrli:startDate>
    <xbrli:endDate>2025-03-06</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image1.jpg
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !) %$# 2(  A$! Q$!_\0
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M%(\>_P#A8>(?_EC17!45^X_7<9_T%8G_ ,'U?_DC_2W^TLQ_Z#\;_P"%5?\
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M+P.6/+\;@<RQL'2RW2&(GA<5A,5C'2P>)H5L/[11Q/MZ==*@\/7]#_X*W?\
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9IO\ ^6'_ -^G]4?\0A_ZJ'_S$_\ X3/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image2.jpg
<TEXT>
begin 644 image2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  = &<# 2(  A$! Q$!_\0
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image3.jpg
<TEXT>
begin 644 image3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" $F C,# 2(  A$! Q$!_\0
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MB%E_S^ZQ_P"#"7_&C_A$++_G]UC_ ,&$O^- '1T5SG_"(67_ #^ZQ_X,)?\
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M1_PA&B?W-0_\&=U_\<KI:* .:_X0C1/[FH?^#.Z_^.4?\(1HG]S4/_!G=?\
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M<U_PA&B?W=1_\&EU_P#'*/\ A"-$_NZC_P"#2Z_^.4 =+17-?\(1HG]W4?\
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M7_QRC_A"-$_NZC_X-+K_ ..4 =+17-?\(1HG]W4?_!I=?_'*/^$(T3^[J/\
MX-+K_P".4 =+17-?\(1HG]W4?_!I=?\ QRC_ (0C1/[NH_\ @TNO_CE '2T5
MS7_"$:)_=U'_ ,&EU_\ '*/^$(T3^[J/_@TNO_CE '2T5S7_  A&B?W=1_\
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M3_\ !K=?_'*/^$)T7TU/_P &MU_\<KI:* .:_P"$)T7TU/\ \&MU_P#'*/\
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MHH YK_A"=%]-3_\ !K=?_'*/^$)T7TU/_P &MU_\<KI:* .:_P"$)T7TU/\
M\&MU_P#'*/\ A"=%]-3_ /!K=?\ QRNEHH YK_A"=%]-3_\ !K=?_'*/^$)T
M7TU/_P &MU_\<KI:* .:_P"$)T7TU/\ \&MU_P#'*/\ A"=%]-3_ /!K=?\
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MM?J_47*[W9VFI:G8Z5 )M4O;:SB+;1)<2K&I/IEB!FET[4K+4[?[1IMY;7<
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MIDFLHW8@2N ,E<\  #V%>HUQ/P9_Y)OI/^]/_P"CI* -3_A!O"7_ $*^A?\
M@OA_^)H_X0;PE_T*^A?^"^'_ .)KHJ* .=_X0;PE_P!"OH7_ (+X?_B:/^$&
M\)?]"OH7_@OA_P#B:Z*B@#G?^$&\)?\ 0KZ%_P""^'_XFC_A!O"7_0KZ%_X+
MX?\ XFNBHH YW_A!O"7_ $*^A?\ @OA_^)H_X0;PE_T*^A?^"^'_ .)KHJ*
M.=_X0;PE_P!"OH7_ (+X?_B:/^$&\)?]"OH7_@OA_P#B:Z*B@#G?^$&\)?\
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M]$-*RU.=_P"$&\)_]"OH7_@OA_\ B:/^$&\)?]"OH7_@OA_^)KHJ*YAG._\
M"#>$O^A7T+_P7P__ !-'_"#>$O\ H5]"_P#!?#_\37144 <[_P (-X2_Z%?0
MO_!?#_\ $T?\(-X2_P"A7T+_ ,%\/_Q-=%10!SO_  @WA+_H5]"_\%\/_P 3
M1_P@WA+_ *%?0O\ P7P__$UT5% '._\ "#>$O^A7T+_P7P__ !-'_"#>$O\
MH5]"_P#!?#_\37144 <[_P (-X2_Z%?0O_!?#_\ $T?\(-X2_P"A7T+_ ,%\
M/_Q-=%10!SO_  @WA+_H5]"_\%\/_P 31_P@WA+_ *%?0O\ P7P__$UT5% '
M._\ "#>$O^A7T+_P7P__ !-'_"#>$O\ H5]"_P#!?#_\37144 <[_P (-X2_
MZ%?0O_!?#_\ $T?\(-X2_P"A7T+_ ,%\/_Q-=%10!SO_  @WA+_H5]"_\%\/
M_P 31_P@WA+_ *%?0O\ P7P__$UT5% '._\ "#>$O^A7T+_P7P__ !-'_"#>
M$O\ H5]"_P#!?#_\37144 <[_P (-X2_Z%?0O_!?#_\ $T?\(-X2_P"A7T+_
M ,%\/_Q-=%10!SO_  @WA+_H5]"_\%\/_P 31_P@WA+_ *%?0O\ P7P__$UT
M5% '._\ "#>$O^A7T+_P7P__ !-'_"#>$O\ H5]"_P#!?#_\37144 <XW@;P
MF!QX7T(?]P^'_P")H^'?_(E:1_UQ_J:Z)NA^E<[\._\ D2M)_P"N7]30!T=%
M%% %+5KR2QM&GBLYKO;RR1,BD#!).78#''K69I_B>VO[J!((+@6\["-+A@H0
MR&/S-F,[L[><XQQC-6/%&FWNJZ>MK87<-L&D!G\V)G$L?.4^5E(R<9.>F1WJ
MA'H-Y!=+.)[>2..0WBVZ1%,S^3Y> =QQ'WQC(]: +<_B*V@U"6"6*=8(W:)K
MKY=GF"/S"F,[L[<G.,<8SFJ?_"71Y\O^SKW[4$\XV^8]PAQGS<[L8]L[O:D;
MPU/=S,;RYC6VE<W4D*1G<LS0^4V'SC;R2!C.>^.*@_X12^\XW?\ :-M]N:#[
M&S?9CL\C&/N[\[^ISG'M0!UEO,D]O'-$VZ.10ZGU!&17'?!G_DF^D_[T_P#Z
M.>NG?2K.;2DTV[MXKJR$:Q-%.@=75<8W C!Z"O._A/X2\.7WP_TJ>^\/Z1<S
MGS5,DUE&[$+*X R5SP  /84 >I45SG_"#^$O^A7T+_P7Q?\ Q-'_  @_A+_H
M5]"_\%\7_P 30!T=%<Y_P@_A+_H5]"_\%\7_ ,31_P (/X2_Z%?0O_!?%_\
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MKC))Q[UB?\(-X2_Z%?0O_!?%_P#$T?\ "#>$O^A7T+_P7Q?_ !- '145SO\
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MT$C[=KDX0[B<@ Y&.?3Z&M;A;JVAGBSY<J+(N1S@C(KC_@S_ ,DXTG_>G_\
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MTG_KE_4UT+=#]*Y[X=_\B7I/_7+^IH Z.BBB@"IJEFNH:?<VDC,B3QF,LO4
MCM5"\TJXGOH[K[:S+;9>VMVC4(DOEE Q8#<?O-Q[UM44 <Z/#2S7!EO;EY(Y
M"9I8%4!#,8O+9P>H&TGCIDYJO_PB/S>=_:5Q]L,?V<S^6F3!C'EXQC_@76NJ
MHH IS:997&F#3[JUAN++8L9@G02(RC& 0>#T%>=?";PEX<O_ (?Z5<7WA_2+
MF=O-4R364;L0)7 &2,\  #V KU&N)^#/_)-])_WI_P#T=)0!I_\ "#>$O^A7
MT+_P7Q?_ !-'_"#>$O\ H5]"_P#!?%_\371T4 <Y_P (-X2_Z%?0O_!?%_\
M$TO_  @WA+_H5]"_\%\7_P 37144 <Y_P@WA/_H5]"_\%\7_ ,32_P#"#>$O
M^A7T+_P7Q?\ Q-=%10!SO_""^$O^A7T+_P %\7_Q-'_""^$O^A7T+_P7Q?\
MQ-=%10!SO_""^$O^A7T+_P %\7_Q-'_""^$O^A7T+_P7Q?\ Q-=%10!SO_""
M^$O^A7T+_P %\7_Q-'_""^$O^A7T+_P7Q?\ Q-=%10!SO_""^$O^A7T+_P %
M\7_Q-'_""^$O^A7T+_P7Q?\ Q-=%10!SO_""^$O^A7T+_P %\7_Q-'_""^$O
M^A7T+_P7Q?\ Q-=%10!SO_""^$O^A7T+_P %\7_Q-'_""^$O^A7T+_P7Q?\
MQ-=%10!SO_""^$O^A7T+_P %\7_Q-'_""^$O^A7T+_P7Q?\ Q-=%10!SO_""
M^$O^A7T+_P %\7_Q-'_""^$O^A7T+_P7Q?\ Q-=%10!SO_""^$O^A7T+_P %
M\7_Q-'_""^$O^A7T+_P7Q?\ Q-=%10!SO_""^$O^A7T+_P %\7_Q-'_""^$O
M^A7T+_P7Q?\ Q-=%10!SO_""^$O^A7T+_P %\7_Q-'_""^$O^A7T+_P7Q?\
MQ-=%10!SO_""^$O^A7T+_P %\7_Q-'_""^$O^A7T+_P7Q?\ Q-=%10!SO_""
M^$O^A7T+_P %\7_Q-'_""^$O^A7T+_P7Q?\ Q-=%10!SO_""^$O^A7T+_P %
M\7_Q-'_""^$O^A7T+_P7Q?\ Q-=%10!SO_""^$O^A7T+_P %\7_Q-'_""^$O
M^A7T+_P7Q?\ Q-=%10!SO_""^$O^A7T+_P %\7_Q-'_""^$O^A7T+_P7Q?\
MQ-=%10!SO_""^$O^A7T+_P %\7_Q-'_""^$O^A7T+_P7Q?\ Q-=%10!SO_""
M^$O^A7T+_P %\7_Q-'_""^$O^A7T+_P7Q?\ Q-=%10!SO_""^$O^A7T+_P %
M\7_Q-'_""^$O^A7T+_P7Q?\ Q-=%10!SO_""^$O^A7T+_P %\7_Q-'_""^$O
M^A7T+_P7Q?\ Q-=%10!SO_""^$O^A7T+_P %\7_Q-'_""^$O^A7T+_P7Q?\
MQ-=%10!SO_""^$O^A7T+_P %\7_Q-'_""^$O^A7T+_P7Q?\ Q-=%10!SO_""
M^$O^A7T+_P %\7_Q-'_""^$O^A7T+_P7Q?\ Q-=%10!SO_""^$O^A7T+_P %
M\7_Q-'_""^$O^A7T+_P7Q?\ Q-=%10!SO_""^$O^A7T+_P %\7_Q-'_""^$O
M^A7T+_P7Q?\ Q-=%10!SO_""^$O^A7T+_P %\7_Q-'_""^$O^A7T+_P7Q?\
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M5SG_  @OA+_H5]"_\ (O_B:/^$%\)?\ 0KZ%_P" $7_Q- '1T5SG_""^$O\
MH5]"_P# "+_XFC_A!?"7_0KZ%_X 1?\ Q- '1T5SG_""^$O^A7T+_P  (O\
MXFC_ (07PE_T*^A?^ $7_P 30!T=%<Y_P@OA+_H5]"_\ (O_ (FC_A!?"7_0
MKZ%_X 1?_$T ='17.?\ ""^$O^A7T+_P B_^)H_X07PE_P!"OH7_ ( 1?_$T
M ='17.?\(+X2_P"A7T+_ , (O_B:/^$%\)?]"OH7_@!%_P#$T ='17.?\(+X
M2_Z%?0O_   B_P#B:/\ A!?"7_0KZ%_X 1?_ !- '1T5SG_""^$O^A7T+_P
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M_P")H_X07PE_T*^A?^ $7_Q- '1T5SG_  @OA+_H5]"_\ (O_B:/^$%\)?\
M0KZ%_P" $7_Q- '1T5SG_""^$O\ H5]"_P# "+_XFC_A!?"7_0KZ%_X 1?\
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M&2W_ +.B;4(&D\^(7)\M514<E7V98E9%P"HYR"1C) .HKB?@S_R3?2?]Z?\
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M%HW_ ('1?_%4 ;M%87_"8^&?^ABT;_P.B_\ BJ/^$Q\,_P#0Q:-_X'1?_%4
M;M%87_"8^&?^ABT;_P #HO\ XJC_ (3'PS_T,6C?^!T7_P 50!NT5A?\)CX9
M_P"ABT;_ ,#HO_BJ/^$Q\,_]#%HW_@=%_P#%4 ;M%87_  F/AG_H8M&_\#HO
M_BJ/^$Q\,_\ 0Q:-_P"!T7_Q5 &[16%_PF/AG_H8M&_\#HO_ (JC_A,?#/\
MT,6C?^!T7_Q5 &[16%_PF/AG_H8M&_\  Z+_ .*H_P"$Q\,_]#%HW_@=%_\
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M (2_PU_T,.C_ /@;%_\ %4?\)?X:_P"AAT?_ ,#8O_BJ?_PBOA[_ * .D_\
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M /"*^'O^@#I/_@''_P#$T?\ "*^'O^@#I/\ X!Q__$T ,_X2_P -?]##H_\
MX&Q?_%4?\)?X;_Z&'1__  -B_P#BJ=_PBOA[_H Z3_X!Q_\ Q-4M&\#^'=-T
MV&T&DZ=<"/=B26TC+'+$\G'OB@"W_P )?X:_Z&'1_P#P-B_^*H_X2_PU_P!#
M#H__ (&Q?_%4_P#X17P]_P! '2?_  #C_P#B:/\ A%?#W_0!TG_P#C_^)H 9
M_P )?X:_Z&'1_P#P-B_^*H_X2_PU_P!##H__ (&Q?_%4_P#X17P]_P! '2?_
M  #C_P#B:/\ A%?#W_0!TG_P#C_^)H 9_P )?X:_Z&'1_P#P-B_^*H_X2_PU
M_P!##H__ (&Q?_%4[_A%?#W_ $ =)_\  ./_ .)JF_@?P\^L17XTC3@8[=[?
MR1:1[&W,K;B-O4;,#ZF@"U_PE_AK_H8='_\  V+_ .*H_P"$O\-?]##H_P#X
M&Q?_ !5._P"$5\/?] '2?_ ./_"E_P"$5\/?] '2?_ ./_XF@!G_  E_AK_H
M8='_ / V+_XJC_A+_#7_ $,.C_\ @;%_\53_ /A%?#W_ $ =)_\  ./_ .)H
M_P"$5\/?] '2?_ ./_XF@!G_  E_AK_H8='_ / V+_XJC_A+_#7_ $,.C_\
M@;%_\53O^$5\/?\ 0!TG_P  X_\ XFJ6K>!_#VHV@MSI&G0#S8I=\5I&#\DB
MOC[O0[<'V)H M_\ "7^&O^AAT?\ \#8O_BJ/^$O\-?\ 0PZ/_P"!L7_Q5/\
M^$5\/?\ 0!TG_P  X_\ XFC_ (17P]_T =)_\ X__B: &?\ "7^&O^AAT?\
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M S_A+_#7_0PZ/_X&Q?\ Q5'_  E_AK_H8='_ / V+_XJG_\ "*^'O^@#I/\
MX!Q__$TG_"*^'O\ H Z3_P" <?\ \30 W_A+_#7_ $,.C_\ @;%_\51_PE_A
MK_H8='_\#8O_ (JJEWX'\/7-_871TC3H_LCNXC2TC"R;D*X;CD#.?J*N_P#"
M*^'O^@#I/_@''_\ $T -_P"$O\-?]##H_P#X&Q?_ !5'_"7^&O\ H8='_P#
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M  #  [4Z@ HHHH *SM7O+NWB"Z99I>7).-CS>6B#!.6;#$9Q@<'FI=5>^2V
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L10 M%%% !1110 4F*** %HHHH **** "DQ110  8I:** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image4.jpg
<TEXT>
begin 644 image4.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" $H C # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#Z;NM6L;2^
M@M+FX6.XG_U:,#\WIST[&DTG6+#5XFDTZX6>-<9900.>G4<UDZ\M]=ZY86IT
MR>?28BL\DT<D0#2AOE4AG#;5^\< YX Z&JFCVT^G)<0BSU"ST^<16MM:S3BX
M>)L,&<$.VU,;>-W&T\#/(!N+X@TI[6>Y6^B:"%@CL">">F/7/;'6GPZWILUU
M#;17D3S3()(U!SN!&1^/MUKE+?2=37[)=/8,KV$5I +=9(R9_*\S<R'=@ ^8
M-NXJ>#G%)HV@ZE:S)!-;8CFOUU%IA(I6(<GRB,Y+=N 5]Z .\S2@YKC/BQ/?
M:=X/NM4TO4;JRN;,HRB'85DW2(I#!E.1@GICK6@-!U7_ *&?4/\ OS#_ /$4
M ='17.?V#JO_ $,^H?\ ?B'_ .(H_L'5?^AGU#_OQ#_\10!T=%<Y_8.J_P#0
MSZA_WXA_^(H_L'5?^AGU#_OQ#_\ $4 ='17.?V#JO_0SZA_WXA_^(H_L'5?^
MAGU#_OQ#_P#$4 ='17.?V#JO_0SZA_WXA_\ B*/[!U7_ *&?4/\ OQ#_ /$4
M ='17.?V#JO_ $,^H?\ ?B'_ .(H_L'5?^AGU#_OQ#_\10!T=%<Y_8.J_P#0
MSZA_WXA_^(H_L'5?^AGU#_OQ#_\ $4 ='17.?V#JO_0SZA_WXA_^(H_L'5?^
MAGU#_OQ#_P#$4 ='17.?V#JO_0SZA_WXA_\ B*/[!U7_ *&?4/\ OQ#_ /$4
M ='17.?V#JO_ $,^H?\ ?B'_ .(H_L'5?^AGU#_OQ#_\10!T=%<Y_8.J_P#0
MSZA_WXA_^(H_L'5?^AGU#_OQ#_\ $4 ='17.?V#JO_0SZA_WXA_^(H_L'5?^
MAGU#_OQ#_P#$4 ='17.?V#JO_0SZA_WXA_\ B*/[!U7_ *&?4/\ OQ#_ /$4
M ='17.?V#JO_ $,^H?\ ?B'_ .(H_L'5?^AGU#_OQ#_\10!T=%<Y_8.J_P#0
MSZA_WXA_^(H_L'5?^AGU#_OQ#_\ $4 ='17.?V#JO_0SZA_WXA_^(H_L'5?^
MAGU#_OQ#_P#$4 ='17.?V#JO_0SZA_WXA_\ B*/[!U7_ *&?4/\ OQ#_ /$4
M ='17.?V#JO_ $,^H?\ ?B'_ .(H_L'5?^AGU#_OQ#_\10!T=%<Y_8.J_P#0
MSZA_WXA_^(H_L'5?^AGU#_OQ#_\ $4 ='17.?V#JO_0SZA_WXA_^(H_L'5?^
MAGU#_OQ#_P#$4 ='17.?V#JO_0SZA_WXA_\ B*/[!U7_ *&?4/\ OQ#_ /$4
M ='17.?V#JO_ $,^H?\ ?B'_ .(H_L'5?^AGU#_OQ#_\10!T=%<Y_8.J_P#0
MSZA_WXA_^(H_L'5?^AGU#_OQ#_\ $4 ='17.?V#JO_0SZA_WXA_^(H_L'5?^
MAGU#_OQ#_P#$4 ='17.?V#JO_0SZA_WXA_\ B*/[!U7_ *&?4/\ OQ#_ /$4
M ='17.?V#JO_ $,^H?\ ?B'_ .(H_L'5?^AGU#_OQ#_\10!T=%<Y_8.J_P#0
MSZA_WXA_^(H_L'5?^AGU#_OQ#_\ $4 ='17.?V#JO_0SZA_WXA_^(H_L'5?^
MAGU#_OQ#_P#$4 ='17.?V#JO_0SZA_WXA_\ B*/[!U7_ *&?4/\ OQ#_ /$4
M ='17.?V#JO_ $,^H?\ ?B'_ .(H_L'5?^AGU#_OQ#_\10!T=%<Y_8.J_P#0
MSZA_WXA_^(H_L'5?^AGU#_OQ#_\ $4 ='17.?V#JO_0SZA_WXA_^(H_L'5?^
MAGU#_OQ#_P#$4 ='17%>(;;5]%TMKY/$-Y.8Y8E,<D,05@TBJ<X7/0UVM !B
MC%%% !BBBB@#BOC-_P DTUGZ1?\ HY*[4=*XKXS?\DTUGZ1?^CDKM1TH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .;^(7_ "*MQ_UVM_\
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M_P!#5X@_[ZM__C- '345S7_",7?_ $-7B#_OJW_^,T?\(Q=_]#5X@_[ZM_\
MXS0!TM%<U_PC%W_T-7B#_OJW_P#C-'_",7?_ $-7B#_OJW_^,T =+17-?\(Q
M=_\ 0U>(/^^K?_XS1_PC%W_T-7B#_OJW_P#C- '2T5S7_",7?_0U>(/^^K?_
M .,T?\(Q=_\ 0U>(/^^K?_XS0!TM%<U_PC%W_P!#5X@_[ZM__C-'_",7?_0U
M>(/^^K?_ .,T =+17-?\(Q=_]#5X@_[ZM_\ XS1_PC%W_P!#5X@_[ZM__C-
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MTM%<U_PC%W_T-7B#_OJW_P#C-'_",7?_ $-7B#_OJW_^,T =+17-?\(Q=_\
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M!YDRW\:!)8I9)&D)')_OD$'@UQ7@G]G:XTZ]TW5=:UQTUJTOVN9)K-S)YJ
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MLBO(K'L2Y&!V S7G]WX(T,_!^^@\$^*_[<U+0I_[52*V9'19-_W@@0ON\L8
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M^5,ALK6&3?#;01N/XDC -6**-0*\UG:SONFMX9&QC<Z!C^M/:")XA$\2-&
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_A#]-_Y^M=_\'E[_ /'J .BHKG?^$/TW_GZUW_P>7O\ \>H_X0_3?^?K7?\
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MUKO_ (/+W_X]0!T5&*YW_A#]-_Y^M=_\'E[_ /'J/^$/TW_GZUW_ ,'E[_\
M'J .B->5_$'X*^'_ !KX@N-7NYKBTNKBW2"7R%7YBKJP?D?>VJ4SZ'VKLO\
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M(O\ T<E=J.E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ6H2-<3I,I5P,[4!!Z?*,_C7K=%:JM)4W26S=_N%;6X4445D,**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#F_B%_P BK<?]=K?_ -')725S?Q"_Y%6X_P"NUO\ ^CDKI*  G )/:L?P
M[K\&NZ>;V"WF@M\!E:5XFW C.?D=L<=C@^U;!Z5S.GZ3>VVH3S3Q612]40SB
MU4QI&BJY#8/+,2V/H!Z4 .3Q=;2>6D5A?O<RJLL-N%C#RQ,&(D&7P%PK<$AN
M,8SQ5F'Q+93W4$<"3R03>6!=!1Y89UW(IR=V2"#]W'/)%8\'AC4H+FUO$O+1
MKVTA2TAW1ML:%58989SN._/''%6++PO+9SVD,5TC:?"\,S!D/FF2) @YZ8.T
M$]Z *OQF_P"2:ZS](O\ T<E=H#7G_P =;:!OAOJM[<27"?8U24>7/(BD>8F=
MRJ0'&!T8&N$/Q-^&LEK;R66I^+;ZXF8@6EKJ&H/,@'5F7S0 /Q_KC6%&I45X
M1N*Z1[Y1FOGVX^(?AV!4>7P_\2$CF8- [7UZ!+%G#2?Z[C'/'M[U0T_XA6QB
M74=4\-^+K;PS<78AMM8&OW@A,3/L61]TO'<GGCI6BPE9J]@YD?2-)FO%?$_C
M+P!I.B7UWI^OZGJE[ PAAL[;Q!>L\\Q&55<2G(YZCCMUKFK]_B78"1W\*7UW
M%93+'<?9=?U!C=!AD&$&7.%X!.#S^.%'"U);Z>NGY@Y(^D,T9KRWX?2:/XIT
MG?>3:UINL0SR6MWITGB&\,D,J$Y7_79(Q@@UF^*/$W@_2+L:=I-UXE\0ZVSE
M!I^E:U>S2+@X;<1+M7'N<U"HU')P2U"Z/9,T9KP)/B1X$,*1$^-6UOSFMY-'
MBU*]>ZCD7.X$><%(&T]#GVJ&/Q"?'$[:9\+[;Q&TR,%O-3U+6+V.&QR<$%#-
MEW_V1^57]5JK62LO,.9'T%FC(KP5?A+\0!J4$;?$S57TU^9Y5N9UFCP,X0;R
MI!.1ST '4TW5OA/\08]2@CT;XCZM+I\B8GGO;V<2Q-GJBHV&XQU--4(/_EXO
MQ_R"[['NUW=V]G TUW/%!$HR7D<*H_$UYIJ/Q;CENIXO"'AG6O%$-O+Y4MY8
M(#;@X!(63G<1GI@?6LW3?@?;WS6DOCSQ%K/B9XHW5[>YNI! 6)^5E^;<,#WY
M//M7;Z9\/M!TJRBL],_M:SM(AB."#6+R-%^@$N*7[FG_ 'G]R_S#4XO4-2^(
MWCH_8-&TVX\#V:*7GU"]*2S29 *)&HZ=?F/;!&<\&C>?!'57@W6GC_78[F<9
MN_,;?'*[J%G8#/&X9P.WO7IG_"':;_S]Z]_X/+W_ ..T?\(=IO\ S]Z]_P"#
MR]_^.TUBIPTIV2_KN'*NIQD/P"\!0ZM%>+ILYB154V9N6,$A'1F7J3GG&<>U
M=SX=\)Z%X;M[F#0M+M;*&XF^T2I$G#/Z\],=@.!VQ4/_  AVF_\ /UKW_@\O
M?_CM'_"':;_S]:]_X/+W_P".UG.O4J*TI-@DD=$!BEKG/^$.TW_GZU[_ ,'E
M[_\ ':/^$.TW_GZU[_P>7O\ \=K(9T=%<Y_PAVF_\_6O?^#R]_\ CM'_  AV
MF_\ /UKW_@\O?_CM '1T5SG_  AVF_\ /UKW_@\O?_CM'_"':;_S]:]_X/+W
M_P".T ='BJFG:=9Z;$\6GVL%K%)(TKI#&$#.QRS$#N3U-8__  AVF_\ /UKW
M_@\O?_CM'_"':;_S]:]_X/+W_P".T ='17.?\(=IO_/UKW_@\O?_ ([1_P (
M=IO_ #]:]_X/+W_X[0!T=%<Y_P (=IO_ #]:]_X/+W_X[1_PAVF_\_6O?^#R
M]_\ CM '1T5SG_"':;_S]:]_X/+W_P".T?\ "':;_P _6O?^#R]_^.T ='17
M.?\ "':;_P _6O?^#R]_^.T?\(=IO_/UKW_@\O?_ ([0!T=%<Y_PAVF_\_6O
M?^#R]_\ CM'_  AVF_\ /UKW_@\O?_CM '1T5SG_  AVF_\ /UKW_@\O?_CM
M'_"':;_S]:]_X/+W_P".T ='17.?\(=IO_/UKW_@\O?_ ([1_P (=IO_ #]:
M]_X/+W_X[0!T=%<Y_P (=IO_ #]:]_X/+W_X[1_PAVF_\_6O?^#R]_\ CM '
M1T5SG_"':;_S]:]_X/+W_P".T?\ "':;_P _6O?^#R]_^.T ='17.?\ "':;
M_P _6O?^#R]_^.T?\(=IO_/UKW_@\O?_ ([0!T=%<Y_PAVF_\_6O?^#R]_\
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M_)--9^D7_HY*[4=* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@.XR%QD>M9P^%O@T_P#,%3_P(E_^+H [:BN)_P"%6>#?^@*O_@1+_P#%T?\
M"K/!O_0%7_P(E_\ BZ .VHKB?^%6>#?^@*O_ ($2_P#Q='_"K/!O_0%7_P "
M)?\ XN@#MJ*XG_A5G@S_ * J_P#@1+_\75+3OA+X7MS=_:]/6X$EPTD7[Z4>
M5&0,)]_M@_G0!Z'17$_\*L\&_P#0%7_P(E_^+H_X59X-_P"@*O\ X$2__%T
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M (2^%X)KYKG3EG2:X,D"^=*/)38HV??Y^8,?^!4 >A45Q/\ PJSP;_T!5_\
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M&]@^^6WEMI&Y#=5B>)3C^'.SC=GCKO#.B+HFG1V[7$MW.J*C3RC!( P !T4
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M\OEO*BG@KO(&X*2K88$9R.HH U)?%#:EK3Z?87#VL3P^6)3;DRPRL1L=D;^
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&*** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45929999190912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Mar. 06, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000947263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">TORONTO DOMINION BANK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-283969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45930007528928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Mar. 06, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvDsclsr', window );">Narrative Disclosure</a></td>
<td class="text"><div style="text-align: center; font-family: Arial; font-size: 12pt;">The maximum aggregate offering price of the securities to which the prospectus relates is $500,000. The prospectus is a final prospectus for the related offering.</div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvDsclsr">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvDsclsr</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M/A.MZ>=%;SC=A!Y]U(XZ/BPK&K%H? #M%UJ[K>';?AC:V7]02P,$%     @
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M<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ 2X=G6B-A4GE- 0  N0(
M  \   !X;"]W;W)K8F]O:RYX;6RU4EU+PT 0_"OA?H!)BQ8LC2^6:D&T&.G[
M)=DT2^\C[%Y:VU_O)B$8$,07G_9V=IF;F;O5V=,Q]_X8?5KC.%5U",TRCKFH
MP6J^\0TXF52>K [2TB'FAD"77 ,$:^)YDBQBJ]&IA]7(M:-XVO@ 14#O!.R
M/<*9O^==&YV0,4>#X9*J_FQ 118=6KQ"F:I$15S[\[,GO'H7M,D*\L:D:C8,
M]D !BQ]PUHG\T#GW2-#YNQ8AJ5HD0E@A<>@W>GXM&D\@RT/7!K]!$X#6.L 3
M^;9!=^AHQ$4\L='G,-8AQ"7])49?55C VA>M!1>&' E,)]!QC0VKR&D+J<K:
MW"*SP)TIN65;#@:#*)O$14N4 6W+7N/_Z=D <)2UUFJZ3!3-?U$T[U,;HRJA
M0@?EJ["QX/)LQ8ZBKO3.YK=WLWMYGM:81\'>W(O7Y9C\^&L>O@!02P,$%
M  @ 2X=G6HWW+%JT    B0(  !H   !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN
M<F5L<\6230J#,!!&KQ)R@([:TD515]VX+5X@Z/B#T83,E.KM:W6A@2ZZD:["
M-R'O>S")'Z@5MV:@IK4DQEX/E,B&V=X J&BP5W0R%H?YIC*N5SQ'5X-51:=J
MA"@(KN#V#)G&>Z;()XN_$$U5M07>3?'L<> O8'@9UU&#R%+DRM7(B811;V."
MY0A/,UF*K$RDR\I0PK^%(D\H.E"(>-)(F\V:O?KS@?4\O\6M?8GKT-_)Y>,
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M4')O<',O8V]R92YX;6Q02P$"% ,4    " !+AV=:F5R<(Q &  "<)P  $P
M            @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (
M $N'9UH' 79.; (  ,L&   8              " @0X(  !X;"]W;W)K<VAE
M971S+W-H965T,2YX;6Q02P$"% ,4    " !+AV=:^+T1SFP"  # !0  &
M            @(&P"@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#
M%     @ 2X=G6GH!6\GH @  Y0T   T              ( !4@T  'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    " !+AV=:EXJ[',     3 @  "P
M    @ %E$   7W)E;',O+G)E;'-02P$"% ,4    " !+AV=:(V%2>4T!  "Y
M @  #P              @ %.$0  >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ 2X=G6HWW+%JT    B0(  !H              ( !R!(  'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ 2X=G6FZG)+P> 0  5P0
M !,              ( !M!,  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/  H "@"$ @   Q4

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>9</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="exfilingfees.htm">exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="7">http://xbrl.sec.gov/ffd/2024q2</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
     ]
    }
   },
   "keyStandard": 9,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/ffd/2024q2": 3,
    "http://xbrl.sec.gov/dei/2024": 1
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 107,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024q2": 7,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001140361-25-007645-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-007645-xbrl.zip
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MIHY\47$9TH4)L.%_ &CR"-K8 ;IEAOND)18NUU%)5;^":9QC*K/0M"!@6\Z
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4!08      0 ! #X    #"      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
      xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000947263</identifier>
        </entity>
        <period>
            <startDate>2025-03-06</startDate>
            <endDate>2025-03-06</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <ffd:FormTp contextRef="c0" id="ixv-31">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-32">TORONTO DOMINION BANK</dei:EntityRegistrantName>
    <ffd:NrrtvDsclsr contextRef="c0" id="ixv-26">&lt;div style="text-align: center; font-family: Arial; font-size: 12pt;"&gt;The maximum aggregate offering price of the securities to which the prospectus relates is $500,000. The prospectus is a final prospectus for the related offering.&lt;/div&gt;</ffd:NrrtvDsclsr>
    <ffd:NrrtvMaxAggtOfferingPric contextRef="c0" decimals="0" id="ixv-33" unitRef="usd">500000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c0" id="ixv-34">true</ffd:FnlPrspctsFlg>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-37">0000947263</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="c0" id="ixv-38">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:RegnFileNb contextRef="c0" id="ixv-39">333-283969</ffd:RegnFileNb>
    <ffd:SubmissnTp contextRef="c0" id="ixv-40">424B2</ffd:SubmissnTp>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
